000206533712/312026Q1falseoneonexbrli:sharesiso4217:USDxbrli:purecpep:segmentiso4217:EURiso4217:JPYiso4217:AUDiso4217:INRiso4217:CADcpep:classiso4217:USDxbrli:sharescpep:investment00020653372026-01-012026-03-310002065337cpep:ClassASUnitsMember2026-04-300002065337cpep:ClassAIUnitsMember2026-04-300002065337cpep:ClassEAUnitsMember2026-04-300002065337cpep:ClassESUnitsMember2026-04-300002065337cpep:ClassEIUnitsMember2026-04-300002065337cpep:ClassCUnitsMember2026-04-3000020653372026-03-3100020653372025-12-310002065337cpep:ClassAUnitsMember2025-12-310002065337cpep:ClassAUnitsMember2026-03-310002065337cpep:ClassSUnitsMember2026-03-310002065337cpep:ClassSUnitsMember2025-12-310002065337cpep:ClassDUnitsMember2026-03-310002065337cpep:ClassDUnitsMember2025-12-310002065337cpep:ClassIUnitsMember2025-12-310002065337cpep:ClassIUnitsMember2026-03-310002065337cpep:ClassAAUnitsMember2026-03-310002065337cpep:ClassAAUnitsMember2025-12-310002065337cpep:ClassASUnitsMember2026-03-310002065337cpep:ClassASUnitsMember2025-12-310002065337cpep:ClassADUnitsMember2025-12-310002065337cpep:ClassADUnitsMember2026-03-310002065337cpep:ClassAIUnitsMember2026-03-310002065337cpep:ClassAIUnitsMember2025-12-310002065337cpep:ClassEAUnitsMember2026-03-310002065337cpep:ClassEAUnitsMember2025-12-310002065337cpep:ClassESUnitsMember2026-03-310002065337cpep:ClassESUnitsMember2025-12-310002065337cpep:ClassEDUnitsMember2026-03-310002065337cpep:ClassEDUnitsMember2025-12-310002065337cpep:ClassEIUnitsMember2026-03-310002065337cpep:ClassEIUnitsMember2025-12-310002065337cpep:ClassCUnitsMember2026-03-310002065337cpep:ClassCUnitsMember2025-12-310002065337cpep:ClassCGUnitsMember2026-03-310002065337cpep:ClassCGUnitsMember2025-12-3100020653372025-02-112025-12-310002065337cpep:ClassASUnitsMember2025-02-110002065337cpep:ClassAIUnitsMember2025-02-110002065337cpep:ClassEAUnitsMember2025-02-110002065337cpep:ClassESUnitsMember2025-02-110002065337cpep:ClassEIUnitsMember2025-02-110002065337cpep:ClassCUnitsMember2025-02-1100020653372025-02-110002065337cpep:ClassASUnitsMember2025-02-112025-03-310002065337cpep:ClassAIUnitsMember2025-02-112025-03-310002065337cpep:ClassEAUnitsMember2025-02-112025-03-310002065337cpep:ClassESUnitsMember2025-02-112025-03-310002065337cpep:ClassEIUnitsMember2025-02-112025-03-310002065337cpep:ClassCUnitsMember2025-02-112025-03-3100020653372025-02-112025-03-310002065337cpep:ClassASUnitsMember2025-03-310002065337cpep:ClassAIUnitsMember2025-03-310002065337cpep:ClassEAUnitsMember2025-03-310002065337cpep:ClassESUnitsMember2025-03-310002065337cpep:ClassEIUnitsMember2025-03-310002065337cpep:ClassCUnitsMember2025-03-3100020653372025-03-310002065337cpep:ClassASUnitsMember2026-01-012026-03-310002065337cpep:ClassAIUnitsMember2026-01-012026-03-310002065337cpep:ClassEAUnitsMember2026-01-012026-03-310002065337cpep:ClassESUnitsMember2026-01-012026-03-310002065337cpep:ClassEIUnitsMember2026-01-012026-03-310002065337cpep:ClassCUnitsMember2026-01-012026-03-3100020653372025-02-100002065337Other Investments in Portfolio Companies 12026-03-310002065337cpep:PortfolioCompanyMemberus-gaap:AerospaceSectorMember2026-03-310002065337Other Investments in Portfolio Companies 22026-03-310002065337cpep:PortfolioCompanyMembercpep:ConsumerServicesMember2026-03-310002065337Other Investments in Portfolio Companies 32026-03-310002065337cpep:PortfolioCompanyMemberus-gaap:FinancialServicesSectorMember2026-03-310002065337Knack RCM2026-03-310002065337Tarrytown Expocare Pharmacy2026-03-310002065337Vantive2026-03-310002065337Other Investments in Portfolio Companies 42026-03-310002065337cpep:PortfolioCompanyMemberus-gaap:HealthcareSectorMember2026-03-310002065337Waste Services Group Pty Ltd2026-03-310002065337TRYT, Inc.2026-03-310002065337Other Investments in Portfolio Companies 52026-03-310002065337Other Investments in Portfolio Companies 62026-03-310002065337Other Investments in Portfolio Companies 72026-03-310002065337cpep:PortfolioCompanyMembercpep:IndustrialsSectorMember2026-03-310002065337Kyoden Co., Ltd2026-03-310002065337Other Investments in Portfolio Companies 82026-03-310002065337Other Investments in Portfolio Companies 92026-03-310002065337Other Investments in Portfolio Companies 102026-03-310002065337cpep:PortfolioCompanyMemberus-gaap:TechnologySectorMember2026-03-310002065337cpep:PortfolioCompanyMember2026-03-310002065337srt:AmericasMemberus-gaap:EquitySecuritiesMember2026-03-310002065337srt:EuropeMemberus-gaap:EquitySecuritiesMember2026-03-310002065337country:AUus-gaap:EquitySecuritiesMember2026-03-310002065337country:JPus-gaap:EquitySecuritiesMember2026-03-310002065337cpep:OtherAsiaMemberus-gaap:EquitySecuritiesMember2026-03-310002065337Other Investments in affiliated investee funds 1 | Affiliated Issuer2026-03-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMemberus-gaap:AerospaceSectorMember2026-03-310002065337Other Investments in affiliated investee funds 2 | Affiliated Issuer2026-03-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMemberus-gaap:FinancialServicesSectorMember2026-03-310002065337Other Investments in affiliated investee funds 3 | Affiliated Issuer2026-03-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMemberus-gaap:HealthcareSectorMember2026-03-310002065337Other Investments in affiliated investee funds 4 | Affiliated Issuer2026-03-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMembercpep:IndustrialsSectorMember2026-03-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember2026-03-310002065337srt:AmericasMemberus-gaap:EquitySecuritiesMemberus-gaap:InvestmentAffiliatedIssuerNoncontrolledMember2026-03-310002065337srt:EuropeMemberus-gaap:EquitySecuritiesMemberus-gaap:InvestmentAffiliatedIssuerNoncontrolledMember2026-03-310002065337Other Investments in Secondaries 1 | Non-Affiliated Issuer2026-03-310002065337us-gaap:InvestmentUnaffiliatedIssuerMembercpep:IndustrialsSectorMember2026-03-310002065337Other Investments in Secondaries 2 | Non-Affiliated Issuer2026-03-310002065337us-gaap:InvestmentUnaffiliatedIssuerMembercpep:VariousSectorMember2026-03-310002065337us-gaap:InvestmentUnaffiliatedIssuerMember2026-03-310002065337srt:AmericasMemberus-gaap:EquitySecuritiesMemberus-gaap:InvestmentUnaffiliatedIssuerMember2026-03-310002065337us-gaap:EquitySecuritiesMember2026-03-310002065337Foreign Currency Forward Contracts2026-03-310002065337Foreign Currency Forward Contracts (liabilities)2026-03-310002065337us-gaap:DerivativeMember2026-03-310002065337Morgan Stanley Institutional Liquidity Funds - Government Portfolio (Institutional Class)2026-03-310002065337us-gaap:CashAndCashEquivalentsMember2026-03-310002065337srt:AmericasMemberus-gaap:CashAndCashEquivalentsMember2026-03-310002065337srt:AmericasMember2026-03-310002065337srt:EuropeMember2026-03-310002065337country:AU2026-03-310002065337country:JP2026-03-310002065337cpep:OtherAsiaMember2026-03-310002065337Other Investments in Portfolio Companies 12025-12-310002065337cpep:PortfolioCompanyMemberus-gaap:AerospaceSectorMember2025-12-310002065337Other Investments in Portfolio Companies 22025-12-310002065337cpep:PortfolioCompanyMembercpep:ConsumerServicesMember2025-12-310002065337Other Investments in Portfolio Companies 32025-12-310002065337cpep:PortfolioCompanyMemberus-gaap:FinancialServicesSectorMember2025-12-310002065337Knack RCM2025-12-310002065337Tarrytown Expocare Pharmacy2025-12-310002065337Other Investments in Portfolio Companies 42025-12-310002065337cpep:PortfolioCompanyMemberus-gaap:HealthcareSectorMember2025-12-310002065337Waste Services Group2025-12-310002065337TRYT Inc.2025-12-310002065337Other Investments in Portfolio Companies 52025-12-310002065337Other Investments in Portfolio Companies 62025-12-310002065337cpep:PortfolioCompanyMembercpep:IndustrialsSectorMember2025-12-310002065337Adastra2025-12-310002065337Ingentis2025-12-310002065337Kyoden Co., Ltd2025-12-310002065337Other Investments in Portfolio Companies 72025-12-310002065337Other Investments in Portfolio Companies 82025-12-310002065337Other Investments in Portfolio Companies 92025-12-310002065337cpep:PortfolioCompanyMemberus-gaap:TechnologySectorMember2025-12-310002065337cpep:PortfolioCompanyMember2025-12-310002065337srt:AmericasMemberus-gaap:EquitySecuritiesMember2025-12-310002065337srt:EuropeMemberus-gaap:EquitySecuritiesMember2025-12-310002065337country:AUus-gaap:EquitySecuritiesMember2025-12-310002065337country:JPus-gaap:EquitySecuritiesMember2025-12-310002065337cpep:OtherAsiaMemberus-gaap:EquitySecuritiesMember2025-12-310002065337Carlyle Moose Coinvestment, L.P. | Affiliated Issuer2025-12-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMemberus-gaap:AerospaceSectorMember2025-12-310002065337Other Investments in Portfolio Companies 1 | Affiliated Issuer2025-12-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMemberus-gaap:FinancialServicesSectorMember2025-12-310002065337Other Investments in Portfolio Companies 2 | Affiliated Issuer2025-12-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMemberus-gaap:HealthcareSectorMember2025-12-310002065337us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember2025-12-310002065337srt:AmericasMemberus-gaap:EquitySecuritiesMemberus-gaap:InvestmentAffiliatedIssuerNoncontrolledMember2025-12-310002065337Audax Private Equity Beacon CF | Non-Affiliated Issuer2025-12-310002065337us-gaap:InvestmentUnaffiliatedIssuerMembercpep:IndustrialsSectorMember2025-12-310002065337Other Investments in Secondaries | Non-Affiliated Issuer2025-12-310002065337us-gaap:InvestmentUnaffiliatedIssuerMembercpep:VariousSectorMember2025-12-310002065337us-gaap:InvestmentUnaffiliatedIssuerMember2025-12-310002065337srt:AmericasMemberus-gaap:EquitySecuritiesMemberus-gaap:InvestmentUnaffiliatedIssuerMember2025-12-310002065337us-gaap:EquitySecuritiesMember2025-12-310002065337Foreign Currency Forward Contracts2025-12-310002065337Foreign Currency Forward Contracts (liabilities)2025-12-310002065337us-gaap:DerivativeMember2025-12-310002065337Morgan Stanley Institutional Liquidity Funds - Government Portfolio (Institutional Class)2025-12-310002065337us-gaap:CashAndCashEquivalentsMember2025-12-310002065337srt:AmericasMember2025-12-310002065337srt:EuropeMember2025-12-310002065337country:AU2025-12-310002065337country:JP2025-12-310002065337cpep:OtherAsiaMember2025-12-310002065337Mantech2025-12-310002065337srt:MinimumMembercpep:DirectInvestmentsSecondaryInvestmentsAndPrimaryCommitmentsMember2026-03-310002065337srt:MaximumMembercpep:DirectInvestmentsSecondaryInvestmentsAndPrimaryCommitmentsMember2026-03-310002065337srt:MinimumMembercpep:LiquidInvestmentsMember2026-03-310002065337srt:MaximumMembercpep:LiquidInvestmentsMember2026-03-310002065337cpep:LimitedPartnerShipUnitClassIAIEICAndCGMembersrt:AffiliatedEntityMember2026-01-012026-03-310002065337us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2026-03-310002065337us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2026-03-310002065337us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2026-03-310002065337us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2026-03-310002065337us-gaap:MoneyMarketFundsMember2026-03-310002065337us-gaap:FairValueInputsLevel1Member2026-03-310002065337us-gaap:FairValueInputsLevel2Member2026-03-310002065337us-gaap:FairValueInputsLevel3Member2026-03-310002065337us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Member2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2026-03-310002065337us-gaap:EquitySecuritiesMember2026-03-310002065337cpep:InvesteeFundsMemberus-gaap:FairValueInputsLevel1Member2026-03-310002065337cpep:InvesteeFundsMemberus-gaap:FairValueInputsLevel2Member2026-03-310002065337cpep:InvesteeFundsMemberus-gaap:FairValueInputsLevel3Member2026-03-310002065337cpep:InvesteeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2026-03-310002065337cpep:InvesteeFundsMember2026-03-310002065337us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2025-12-310002065337us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2025-12-310002065337us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2025-12-310002065337us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2025-12-310002065337us-gaap:MoneyMarketFundsMember2025-12-310002065337us-gaap:FairValueInputsLevel1Member2025-12-310002065337us-gaap:FairValueInputsLevel2Member2025-12-310002065337us-gaap:FairValueInputsLevel3Member2025-12-310002065337us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel1Member2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel2Member2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2025-12-310002065337us-gaap:EquitySecuritiesMember2025-12-310002065337cpep:InvesteeFundsMemberus-gaap:FairValueInputsLevel1Member2025-12-310002065337cpep:InvesteeFundsMemberus-gaap:FairValueInputsLevel2Member2025-12-310002065337cpep:InvesteeFundsMemberus-gaap:FairValueInputsLevel3Member2025-12-310002065337cpep:InvesteeFundsMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2025-12-310002065337cpep:InvesteeFundsMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMember2026-03-310002065337us-gaap:EquitySecuritiesMembercpep:MeasurementInputTerminalGrowthRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMember2026-03-310002065337us-gaap:EquitySecuritiesMembercpep:MeasurementInputTerminalGrowthRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMember2026-03-310002065337us-gaap:EquitySecuritiesMembercpep:MeasurementInputTerminalGrowthRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:MinimumMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:MaximumMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:WeightedAverageMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:MinimumMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:MaximumMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:WeightedAverageMember2026-03-310002065337us-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMember2025-12-310002065337us-gaap:EquitySecuritiesMembercpep:MeasurementInputTerminalGrowthRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MinimumMember2025-12-310002065337us-gaap:EquitySecuritiesMembercpep:MeasurementInputTerminalGrowthRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMember2025-12-310002065337us-gaap:EquitySecuritiesMembercpep:MeasurementInputTerminalGrowthRateMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:WeightedAverageMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:MinimumMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:MaximumMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputEbitdaMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:WeightedAverageMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:MinimumMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:MaximumMember2025-12-310002065337us-gaap:EquitySecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Memberus-gaap:GoodwillImpairmentLossMethodForFairValueDeterminationPriceOfComparableBusinessMembersrt:WeightedAverageMember2025-12-310002065337us-gaap:EquitySecuritiesMember2025-12-310002065337us-gaap:EquitySecuritiesMember2026-01-012026-03-310002065337us-gaap:EquitySecuritiesMember2026-03-310002065337cpep:EuroForeignExchangeContractMember2026-03-310002065337cpep:EuroForeignExchangeContractMember2025-12-310002065337cpep:JapanForeignExchangeContractMember2026-03-310002065337cpep:JapanForeignExchangeContractMember2025-12-310002065337cpep:AustralianDollarForeignExchangeContractMember2026-03-310002065337cpep:AustralianDollarForeignExchangeContractMember2025-12-310002065337cpep:IndianRupeeForeignExchangeContractMember2026-03-310002065337cpep:IndianRupeeForeignExchangeContractMember2025-12-310002065337cpep:CanadianDollarForeignExchangeContractMember2026-03-310002065337cpep:CanadianDollarForeignExchangeContractMember2025-12-310002065337cpep:LimitedPartnerShipUnitClassASAAASEAAndESMember2026-01-012026-03-310002065337cpep:LimitedPartnerShipUnitClassDADAndEDMember2026-01-012026-03-310002065337cpep:LimitedPartnerShipUnitClassIAIEICAndCGMember2026-01-012026-03-310002065337cpep:ClassCUnitsMember2025-10-010002065337cpep:ClassASUnitsMember2025-02-100002065337cpep:ClassAIUnitsMember2025-02-100002065337cpep:ClassEAUnitsMember2025-02-100002065337cpep:ClassESUnitsMember2025-02-100002065337cpep:ClassEIUnitsMember2025-02-100002065337cpep:ClassCUnitsMember2025-02-100002065337cpep:IncentiveAllocationMemberus-gaap:GeneralPartnerMember2026-03-310002065337us-gaap:GeneralPartnerMember2026-03-310002065337us-gaap:GeneralPartnerMember2025-12-310002065337cpep:AdvisoryAgreementMembersrt:AffiliatedEntityMember2026-01-012026-03-310002065337cpep:AnchorUnitsMembersrt:AffiliatedEntityMembercpep:AdvisoryAgreementMember2026-01-012026-03-310002065337cpep:EarlyInvestorUnitsMembersrt:AffiliatedEntityMembercpep:AdvisoryAgreementMember2026-01-012026-03-310002065337cpep:EarlyInvestorUnitsMember2026-03-310002065337srt:AffiliatedEntityMember2026-01-012026-03-310002065337srt:AffiliatedEntityMember2026-03-310002065337srt:AffiliatedEntityMember2025-12-310002065337cpep:OfferingCostsPayableMembersrt:AffiliatedEntityMember2026-03-310002065337us-gaap:OtherLiabilitiesMembersrt:AffiliatedEntityMember2026-03-310002065337cpep:LimitedPartnerShipUnitClassSASAndESMembersrt:AffiliatedEntityMember2026-01-012026-03-310002065337cpep:LimitedPartnerShipUnitClassAAAAndEAMembersrt:AffiliatedEntityMember2026-01-012026-03-310002065337cpep:LimitedPartnerShipUnitClassDADAndEDMembersrt:AffiliatedEntityMember2026-01-012026-03-310002065337srt:AffiliatedEntityMember2025-02-112025-12-310002065337cpep:UnaffiliatedInvesteeFundsMember2026-03-310002065337cpep:AffiliatedInvesteeFundsMember2026-03-310002065337us-gaap:SubsequentEventMember2026-04-012026-05-140002065337us-gaap:SubsequentEventMember2026-04-012026-05-310002065337cpep:ApprovedWarehousedInvestmentsMembercpep:WarehousingAgreementMemberus-gaap:SubsequentEventMember2026-04-012026-05-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT
OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2026
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934 FOR THE TRANSITION PERIOD FROM            TO
Commission File No. 000-56746
 
Carlyle Private Equity Partners Fund, L.P.
(Exact name of Registrant as specified in its charter)
Delaware
 
33-3814841
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification Number)
1001 Pennsylvania Ave., N.W., Suite 220 South,
Washington, DC 20004-2505
(202) 729-5626
(Address of principal executive office) (Zip Code)
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which Registered
N/A
N/A
N/A
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days:    Yes  ☒    No  ☐ 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
 
  
Accelerated filer
 
Non-accelerated filer
 
  
Smaller reporting company
 
Emerging growth company
 
  
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  
As of April 30, 2026, the registrant had the following limited partnership units outstanding: 24,000 Class A-S units, 873,796 Class A-I
units, 164,829 Class E-A units, 12,781 Class E-S units, 2,242,975 Class E-I units and 164,970 Class C units.
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
TABLE OF CONTENTS
 
Part I.
Financial Information
Item 1.
Unaudited Consolidated Financial Statements
Notes to Consolidated Financial Statements ....................................................................................................
Item 2.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk .........................................................................
Item 4.
Controls and Procedures ...................................................................................................................................
Part II.
Other Information
Item 1.
Legal Proceedings ............................................................................................................................................
Item 1A.
Risk Factors ......................................................................................................................................................
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds .........................................................................
Item 3.
Defaults Upon Senior Securities ......................................................................................................................
Item 4.
Mine Safety Disclosures ...................................................................................................................................
Item 5.
Other Information .............................................................................................................................................
Item 6.
Exhibits .............................................................................................................................................................
Signatures .........................................................................................................................................................
Table of Contents
FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q may contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements
include, but are not limited to, statements related to our expectations, estimates, beliefs, projections, future plans and strategies,
anticipated events or trends, and similar expressions and statements that are not historical facts, including our expectations
regarding our future operations, business plans, business and investment strategies and portfolio management and the
performance of our investments. You can identify these forward-looking statements by the use of words such as “outlook,”
“believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,”
“plans,” “estimates,” “anticipates,” or the negative version of these words or other comparable words. Such forward-looking
statements are subject to various risks, uncertainties, and assumptions. Accordingly, there are or will be important factors that
could cause actual outcomes or results to differ materially from those indicated in these statements including, but not limited to,
those described in this Quarterly Report on Form 10-Q and under "Part I, Item 1A. Risk Factors” in our Annual Report on Form
10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (“SEC”) on March 30,
2026, as such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC’s
website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other
cautionary statements that are included in this Quarterly Report on Form 10-Q and in our other periodic filings with the SEC.
We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new
information, future developments, or otherwise, except as required by applicable law.
In this Quarterly Report on Form 10-Q, except where the context suggests otherwise:
the term “Carlyle” refers collectively to The Carlyle Group Inc. and its subsidiaries and affiliated entities;
the term “Carlyle AlpInvest” refers to AlpInvest Private Equity Investment Management, LLC;
the terms “CPEP,” “we,” “us,” “our” and “Fund,” refer to Carlyle Private Equity Partners Fund, L.P., a Delaware
limited partnership, and may include the Feeder, Intermediate Entities, Lower Funds and Parallel Funds, as the context
requires;
the term “CPEP Lux” refers to Carlyle Private Equity Partners – EU, a sub-fund of Carlyle Private Markets S.A.
SICAV – UCI Part II, and a Luxembourg alternative investment fund available to individual investors primarily
domiciled in countries of the European Economic Area, the United Kingdom, Switzerland, Asia and certain other
jurisdictions, together with its related entities;
the term “Feeder” refers to CPEP Feeder, L.P., a Delaware limited partnership;
the term “General Partner” refers to CPEP GP, LLC, a Delaware limited liability company, our general partner;
the term “Intermediate Entity” refers to entities (including corporations) used to acquire, hold or dispose of any
investment asset or otherwise facilitate the Fund’s investment activities;
the term “Investment Advisor” refers to Carlyle Investment Management L.L.C., our investment advisor;
the term “Lower Funds” refers to CPEP Aggregator, Ltd., a Cayman Islands limited company, together with one or
more additional vehicles that aggregate, or may in the future aggregate, the holdings or a portion of the holdings of the
Fund (including any successor vehicles thereto), directly or indirectly through one or more Intermediate Entities;
the term “net asset value” or “NAV” refers to, as the context requires, transactional NAV (i.e., the price at which
transactions in the Fund’s Units are made);
the term “Other Carlyle Accounts” refers to, individually and collectively, any of the following: other funds,
investment vehicles, separate managed account arrangements, special purpose vehicles, co-investors, co-investment
vehicles and/or other similar arrangements sponsored, advised and/or managed by Carlyle or its affiliates, whether
currently in existence or subsequently established, including CPEP Lux;
the term “Parallel Funds” refers to one or more parallel investment vehicles established by, or at the direction of,
Carlyle to facilitate investment by certain investors, including to accommodate legal, tax, regulatory, compliance, or
certain other operational requirements, but excluding CPEP Lux;
Table of Contents
the term “Portfolio Companies” refers to the companies in which the Fund invests; and
the term “Shareholders” refers to holders of our limited partnership units (the “Units”). There are fourteen classes of
Units (each a “Class”): Class A Units (“Class A Units”), Class S Units (“Class S Units”), Class D Units (“Class D
Units”) and Class I Units (“Class I Units” and together with Class A Units, Class S Units and Class D Units, the
“Standard Units”); Class A-A Units (“Class A-A Units”), Class A-S Units (“Class A-S Units”), Class A-D Units
(“Class A-D Units”) and Class A-I Units (“Class A-I Units” and together with Class A-A Units, Class A-S Units and
Class A-D Units, the “Anchor Units” ); Class E-A Units (“Class E-A Units”), Class E-S Units (“Class E-S Units”),
Class E-D Units (“Class E-D Units”) and Class E-I Units (“Class E-I Units” and together with Class E-A Units, Class
E-S Units and Class E-D Units, the “Early Investor Units” and together with the Standard Units and Anchor Units, the
“Investor Units”); and Class C Units (“Class C Units”) and Class CG Units (“Class CG Units”, and together with Class
C Units, “Carlyle Units”).
The Fund is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS
Act”) and the Fund will take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of
1933, as amended (the “1933 Act”).
1
Table of Contents
PART I – FINANCIAL INFORMATION
ITEM 1. Financial Statements
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(Dollars in Thousands, Except Unit Data)
March 31, 2026
December 31, 2025
Assets
(unaudited)
 
Investments, at fair value (cost of $66,958 and $41,722, respectively)
$73,576
$44,900
Derivative assets, at fair value
493
759
Cash and cash equivalents
14,219
11,176
Interest and other income receivable
55
65
Deferred offering costs
1,754
2,146
Receivable from investments
230
Total assets
$90,327
$59,046
Liabilities
Payable for investments purchased
$
$5,770
Derivative liabilities, at fair value
265
359
Management fee payable
36
18
Incentive allocation payable
444
434
Due to affiliate
3,304
2,599
Servicing fees payable
131
74
Offering costs payable
3,212
2,828
Accrued organizational expenses
45
Other accrued expenses and liabilities
983
737
Total liabilities
8,375
12,864
Commitments and contingencies
Net Assets
Class A units, unlimited units authorized, no units issued and outstanding
Class S units, unlimited units authorized, no units issued and outstanding
Class D units, unlimited units authorized, no units issued and outstanding
Class I units, unlimited units authorized, no units issued and outstanding
Class A-A units, unlimited units authorized, no units issued and outstanding
Class A-S units, unlimited units authorized, 29,000 and 29,000 units issued and outstanding as
of March 31, 2026 and December 31, 2025, respectively
648
635
Class A-D units, unlimited units authorized, no units issued and outstanding
Class A-I units, unlimited units authorized, 868,820 and  868,850 units issued and outstanding
as of March 31, 2026 and December 31, 2025, respectively
21,212
20,709
Class E-A units, unlimited units authorized, 48,143 and 0 units issued and outstanding as of
March 31, 2026 and December 31, 2025, respectively
1,327
Class E-S units, unlimited units authorized, 11,050 and 11,050 units issued and outstanding as
of March 31, 2026 and December 31, 2025, respectively
287
281
Class E-D units, unlimited units authorized, no units issued and outstanding
Class E-I units, unlimited units authorized, 1,923,732 and 809,598 units issued and outstanding
as of March 31, 2026 and December 31, 2025, respectively
54,362
22,053
Class C units, unlimited units authorized, 148,072 and 95,584 units issued and outstanding as
of March 31, 2026 and December 31, 2025, respectively
4,116
2,504
Class CG units, unlimited units authorized, no units issued and outstanding
Total net assets
81,952
46,182
Total liabilities and net assets
$90,327
$59,046
See accompanying notes to these consolidated financial statements.
2
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(Dollars in Thousands)
 
Three Months
Ended March 31,
2026
For the Period
from February 11,
2025 (Inception)
through March 31,
2025
Investment income:
Dividend income
$167
$
Interest income
9
Total investment income
176
Expenses:
Organizational expenses
54
Offering cost expense
776
Management fees
131
Incentive allocation
444
Professional fees
678
Administrative fees
234
Other expenses
91
Total expenses
2,408
Management fees waived
(48)
Total expenses after fees waived
2,360
Net investment loss
(2,184)
Net realized gain and change in unrealized appreciation/(depreciation):
Net realized gain on investments
54
Net realized gain on derivative contracts
486
Net change in unrealized appreciation on investments
3,441
Net change in unrealized depreciation on derivative contracts
(172)
Net realized and unrealized gain on investments, including derivative contracts
3,809
Net increase in net assets resulting from operations
$1,625
$
    See accompanying notes to these consolidated financial statements.
3
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED)
(Dollars in Thousands)
Class A-S
Units
Class A-I
Units
Class E-A
Units
Class E-S
Units
Class E-I
Units
Class C
Units
Total Net
Assets
Net Assets at February 11, 2025 (Inception)
$
$
$
$
$
$
$
Proceeds from units issued
1
1
Net Assets at March 31, 2025
$
$
$
$
$
$1
$1
Class A-S
Units
Class A-I
Units
Class E-A
Units
Class E-S
Units
Class E-I
Units
Class C
Units
Total Net
Assets
Net Assets at December 31, 2025
$635
$20,709
$
$281
$22,053
$2,504
$46,182
Proceeds from units issued
1,367
31,338
1,500
34,205
Net investment loss
(20)
(677)
(14)
(10)
(1,376)
(87)
(2,184)
Net realized gain on investments
14
1
36
3
54
Net realized gain on derivative contracts
6
198
(2)
3
254
27
486
Net change in unrealized appreciation on investments
34
1,117
20
16
2,072
182
3,441
Net change in unrealized appreciation on derivative contracts
(5)
(148)
11
(2)
(15)
(13)
(172)
Servicing fees
(2)
(56)
(1)
(59)
Distributions for units redeemed
(1)
(1)
Net Assets at March 31, 2026
$648
$21,212
$1,327
$287
$54,362
$4,116
$81,952
      See accompanying notes to these consolidated financial statements.
4
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(Dollars in Thousands)
 
Three Months
Ended March 31,
2026
For the Period
from February 11,
2025 (Inception)
through March 31,
2025
Cash flows from operating activities:
Net increase in net assets resulting from operations
$1,625
$
Adjustments to reconcile net increase in net assets resulting from operations to net
cash used in operating activities:
Net realized gain on investments
(54)
Net realized gain on derivative contracts
(486)
Net change in unrealized appreciation on investments
(3,441)
Net change in unrealized depreciation on derivative contracts
172
Cost of investments purchased
(25,685)
Proceeds from sales and repayments of investments
505
Proceeds from settlement of derivative contracts
486
Changes in operating assets:
Interest and other income receivable
10
Deferred offering costs
392
Receivable from investment
(230)
Changes in operating liabilities:
Payable for investments purchased
(5,770)
Management fee payable
18
Incentive allocation payable
10
Offering costs payable
384
Due to affiliate
705
Accrued expenses and other liabilities
200
Net cash used in operating activities
(31,159)
Cash flows from financing activities:
Proceeds from issuance of units
34,205
1
Redemption of units
(1)
Servicing fees paid
(2)
Net cash provided by financing activities
34,202
1
Net increase in cash and cash equivalents
3,043
1
Cash and cash equivalents, beginning of period
11,176
Cash and cash equivalents, end of period
$14,219
$1
Supplemental disclosures of non-cash information
Servicing fee payable
$131
$
        See accompanying notes to these consolidated financial statements.
5
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONDENSED CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
As of March 31, 2026
(Dollars in Thousands)
Issuer
Asset
Geography (3)
Fair Value ($) (2)
Fair Value as
Percentage of Net
Assets (%)
Investments in Portfolio Companies
Aerospace & Defense
Other Investments in Portfolio Companies (1)
Americas
$2,724
3.32%
2,724
3.32
Consumer Services
Other Investments in Portfolio Companies (1)
Japan
729
0.89
729
0.89
Financial Services
Other Investments in Portfolio Companies (1)
Americas
7,651
9.34
Total Financial Services
7,651
9.34
Healthcare
Knack RCM
Equity interest held through CA Poppy Holdings
Other Asia
4,814
5.87
Tarrytown Expocare Pharmacy
Equity interests held through CP Maverick
Holdings, L.P. and CP Catapult Holdings, L.P.
Americas
6,518
7.95
Vantive
Equity interest held through CP VIII
Participations S.a.r.l., SICAR
Americas
4,350
5.31
Other Investments in Portfolio Companies (1)
Japan
1,970
2.40
Total Healthcare
17,651
21.53
Industrials
Waste Services Group Pty Ltd
Equity interest held through CAP V Odin, L.P.
Australia
5,633
6.87
TRYT, Inc.
Equity interest held through CJP V HC Holdings
VI, L.P.
Japan
4,779
5.83
Other Investments in Portfolio Companies (1)
Europe
2,117
2.58
Other Investments in Portfolio Companies (1)
Americas
3,697
4.51
Other Investments in Portfolio Companies (1)
Other Asia
1,166
1.42
Total Industrials
17,392
21.21
6
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONDENSED CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
As of March 31, 2026
(Dollars in Thousands)
Issuer
Asset
Geography (3)
Fair Value ($) (2)
Fair Value as
Percentage of Net
Assets (%)
Technologies
Kyoden Co., Ltd
Equity interest held through Fountain Holdings,
L.P.
Japan
$4,523
5.52%
Other Investments in Portfolio Companies (1)
Americas
330
0.41
Other Investments in Portfolio Companies (1)
Japan
736
0.90
Other Investments in Portfolio Companies (1)
Europe
8,264
10.08
Total Technologies
13,853
16.91
Total Investments in Portfolio Companies
60,001
73.20
(Cost: $20,942 Americas, $10,528 Europe, $5,133 Australia, $12,280 Japan, $6,157 Other Asia)
Investments in Affiliated Investee Funds
Aerospace & Defense
Other Investments in affiliated investee funds (1)
Americas
4,022
4.91
4,022
4.91
Financial Services
Other Investments in affiliated investee funds (1)
Americas
371
0.45
371
0.45
Healthcare
Other Investments in affiliated investee funds (1)
Americas
1,448
1.77
1,448
1.77
Industrials
Other Investments in affiliated investee funds (1)
Europe
667
0.81
667
0.81
Total Investments in Affiliated Investee Funds
6,507
7.94
(Cost: $5,198 Americas, $670 Europe )
Investments in Unaffiliated Investee Funds
Industrials
Other Investments in Secondaries (1)
Americas
2,433
2.97
2,433
2.97
7
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONDENSED CONSOLIDATED SCHEDULE OF INVESTMENTS (UNAUDITED)
As of March 31, 2026
(Dollars in Thousands)
Issuer
Asset
Geography (3)
Fair Value ($) (2)
Fair Value as
Percentage of Net
Assets (%)
Various
Other Investments in Secondaries (1)
Americas
$4,635
5.66%
4,635
5.66
Total Investments in Unaffiliated Investee Funds
7,068
8.62
(Cost: $6,050 Americas)
Total Investments
$73,576
89.78%
Derivative Instruments
Foreign Currency Forward Contracts (assets)
$493
0.60%
Foreign Currency Forward Contracts (liabilities)
(265)
(0.32)
Total Derivative Instruments
$228
0.28%
(Cost: $)
Cash Equivalents
Morgan Stanley Institutional Liquidity Funds - Government
Portfolio (Institutional Class)
Americas
$12,710
15.51%
Total Cash Equivalents
$12,710
15.51%
(Cost: $12,710 Americas)
Total Investments, Derivative Instruments and Cash Equivalents
$86,515
105.57%
(Cost: $44,900 Americas, $11,198 Europe, $5,133 Australia, $12,280 Japan, $6,157 Other Asia)
(1)There were no investments in this category that individually exceeded 5% of net assets.
(2)Fair value is determined by the General Partner pursuant to the Fund’s valuation policy (see Note 2, Significant Accounting Policies, and Note 3, Fair Value Measurements, to these
consolidated financial statements).
(3)Geography is generally based on the region where underlying portfolio companies are headquartered. For investments in underlying funds, geographic classification is based on the
primary geographic focus or investment mandate of such funds.
See accompanying notes to these consolidated financial statements.
8
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONDENSED CONSOLIDATED SCHEDULE OF INVESTMENTS
As of December 31, 2025
(Dollars in Thousands)
Issuer
Asset
Geography (4)
Fair Value ($) (2)
Fair Value as
Percentage of Net
Assets (%)
Investments in Portfolio Companies
Aerospace & Defense
Other Investments in Portfolio Companies (1)
Americas
$943
2.04%
943
2.04
Consumer Services
Other Investments in Portfolio Companies (1)
Japan
708
1.53
708
1.53
Financial Services
Other Investments in Portfolio Companies (1)
Americas
3,745
8.11
Total Financial Services
3,745
8.11
Healthcare
Knack RCM
Equity interest held through CA Poppy Holdings
Other Asia
3,098
6.71
Tarrytown Expocare Pharmacy
Equity interests held through CP Maverick
Holdings, L.P. and CP Catapult Holdings, L.P.
Americas
2,993
6.48
Other Investments in Portfolio Companies (1)
Americas
2,126
4.60
Total Healthcare
8,217
17.79
Industrials
Waste Services Group Pty Ltd
Equity interest held through CAP V Odin, L.P.
Australia
3,691
7.99
TRYT, Inc.
Equity interest held through CJP V HC Holdings
VI, L.P.
Japan
2,984
6.46
Other Investments in Portfolio Companies (1)
Europe
2,068
4.48
Other Investments in Portfolio Companies (1)
Americas
1,833
3.97
Total Industrials
10,575
22.90
9
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONDENSED CONSOLIDATED SCHEDULE OF INVESTMENTS
As of December 31, 2025
(Dollars in Thousands)
Issuer
Asset
Geography (4)
Fair Value ($) (2)
Fair Value as
Percentage of Net
Assets (%)
Technologies
Adastra
Equity interest held through CETP V
Participations S.a.r.l., SICAR
Europe
$3,458
7.49%
Ingentis
Equity interest held through CETP V
Participations S.a.r.l., SICAR
Europe
3,465
7.50
Kyoden Co., Ltd
Equity interest held through Fountain Holdings,
L.P.
Japan
3,025
6.55
Other Investments in Portfolio Companies (1)
Americas
330
0.72
Other Investments in Portfolio Companies (1)
Japan
821
1.78
Other Investments in Portfolio Companies (1)
Europe
676
1.46
Total Technologies
11,774
25.50
Total Investments in Portfolio Companies
35,962
77.87
(Cost: $10,301 Americas, $9,095 Europe, $3,478 Australia, $7,850 Japan, $3,098 Other Asia)
Investments in Affiliated Investee Funds
Aerospace & Defense
Partnership interest in Carlyle Moose
Coinvestment, L.P. (3)
Americas
4,024
8.71
Total Aerospace & Defense
4,024
8.71
Financial Services
Other Investments in affiliated investee funds (1)
Americas
361
0.78
361
0.78
Healthcare
Other Investments in affiliated investee funds (1)
Americas
1,627
3.52
Total Healthcare
1,627
3.52
Total Investments in Affiliated Investee Funds
6,011
13.01
(Cost: $5,418 Americas)
10
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONDENSED CONSOLIDATED SCHEDULE OF INVESTMENTS
As of December 31, 2025
(Dollars in Thousands)
Issuer
Asset
Geography (4)
Fair Value ($) (2)
Fair Value as
Percentage of Net
Assets (%)
Investments in Unaffiliated Investee Funds
Industrials
Audax Private Equity Beacon CF
Equity interest through ASP Bluebird, L.P.
Americas
$2,317
5.02%
Total Industrials
2,317
5.02
Various
Other Investments in Secondaries (1)
Americas
610
1.32
Total Various
610
1.32
Total Investments in Unaffiliated Investee Funds
2,927
6.34
(Cost: $2,482 Americas)
Total Investments
$44,900
97.22%
Derivative Instruments
Foreign Currency Forward Contracts (assets)
$759
1.64%
Foreign Currency Forward Contracts (liabilities)
(359)
(0.78)
Total Derivative Instruments
$400
0.87%
(Cost: $)
Cash Equivalents
Morgan Stanley Institutional Liquidity Funds - Government
Portfolio (Institutional Class)
Americas
$10,833
23.46%
Total Cash Equivalents
$10,833
23.46%
(Cost: $10,833 Americas)
Total Investments, Derivative Instruments and Cash Equivalents
$56,134
121.55%
(Cost: $29,034 Americas, $9,095 Europe, $3,478 Australia, $7,850 Japan, $3,098 Other Asia)
11
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
CONDENSED CONSOLIDATED SCHEDULE OF INVESTMENTS
As of December 31, 2025
(Dollars in Thousands)
(1)There were no investments in this category that individually exceeded 5% of net assets.
(2)Fair value is determined by the General Partner pursuant to the Fund’s valuation policy (see Note 2, Significant Accounting Policies, and Note 3, Fair Value Measurements, to these
consolidated financial statements).
(3)The investment includes indirect exposure to the portfolio company, Mantech. The Fund’s total exposure to Mantech is $4.0 million (which represents 8.71% of the Fund’s Net
Assets).
(4)Geography is generally based on the region where underlying portfolio companies are headquartered. For investments in underlying funds, geographic classification is based on the
primary geographic focus or investment mandate of such funds.
See accompanying notes to these consolidated financial statements.
12
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted)(unaudited)
1. ORGANIZATION
Carlyle Private Equity Partners Fund, L.P. (“CPEP” or the “Fund”), a Delaware limited partnership formed on February 11,
2025 (“Inception”), is a private fund exempt from registration pursuant to Section 3(c)(7) of the Investment Company Act of
1940, as amended (the “1940 Act”). CPEP’s investment objective is to generate attractive risk-adjusted returns and achieve
medium-to-long-term capital appreciation through a well-diversified portfolio of private equity investments. CPEP seeks to
achieve its investment objective by providing access to Carlyle’s Global Private Equity (“GPE”) platform, with an emphasis on
its U.S., European, and Asian corporate buyout strategies. CPEP also provides investors access to Secondary Investments (as
defined below) through Carlyle AlpInvest, as well as certain other investment strategies, such as growth, infrastructure and, in
certain instances, Global Credit. We expect to access these private equity investments in a variety of ways, including through:
Direct Investments: Investments in companies and other private assets which may include, without limitation, private
and public investments in equity instruments, preferred equity instruments, convertible debt or equity derivative
instruments, warrants, options, “PIK” (paid-in-kind) notes, mezzanine debt, hybrid capital (including, but not limited
to, structured equity, distressed credit and opportunities arising due to market dislocation), collateralized loan
obligation equity, other debt investments and “PIPE” (private investments in public equity) transactions;
Secondary Investments: Certain secondary investments of AlpInvest Private Equity Investment Management, LLC
(“Carlyle AlpInvest”) which target investments in private equity assets and private equity funds managed by third-
party managers and portfolios of direct private equity investments through privately negotiated transactions (typically
structured through new investment vehicles) in the secondaries market and from time to time may include secondary
market purchases of existing investments in Other Carlyle Accounts; and
Primary Commitments: Capital commitments to investment funds managed by Carlyle or third-party managers.
The Fund may also invest in debt and other types of liquid securities (“Liquid Investments”). CPEP generally seeks to
invest 80% to 90% of its net asset value (“NAV”) in Direct Investments, Secondary Investments, and Primary Commitments
and up to 10% to 20% of its NAV in Liquid Investments. “Carlyle” refers to The Carlyle Group Inc. and its affiliates and its
consolidated subsidiaries (other than portfolio companies of its affiliated funds), a global investment firm which is publicly
traded on the Nasdaq Global Select Market under the symbol “CG”.
CPEP is conducting a continuous private offering of its units in reliance on exemptions from the registration requirements
of the Securities Act of 1933, as amended (the “1933 Act”) to investors that are both (i) accredited investors (as defined in
Regulation D under the 1933 Act) and (ii) qualified purchasers (as defined in the 1940 Act and the rules thereunder). Structured
as a perpetual life investment solution, CPEP accepts fully funded subscriptions monthly and aims to provide limited partners a
liquidity option by means of a quarterly redemption program.
In addition, CPEP Feeder, L.P. (the “Feeder”) was formed to facilitate investments by certain investors with specific tax
considerations. The Feeder invests substantially all of its assets in the Fund and, as a result, its financial position and results of
operations are dependent on those of the Fund.
CPEP commenced operations on October 1, 2025 (the “Commencement Date” or “Initial Closing Date”), when the Fund
sold Units in its continuous private offering and commenced investing. CPEP’s first fiscal period ended December 31, 2025.
CPEP GP, LLC (the “General Partner”), a Delaware limited liability company, serves as the general partner of the Fund.
On September 2, 2025, CPEP General Partner, L.P. (the “Original General Partner”), a Delaware limited partnership which
served as the original general partner of the Fund, assigned, transferred and conveyed all of its general partner interests in the
Fund to the General Partner. Overall responsibility for the Fund’s oversight rests with the General Partner, subject to certain
oversight rights held by the Fund’s board of directors (the “Board”) with respect to periodic reports under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) and certain situations involving conflicts of interest, or other matters
as deemed appropriate by the General Partner in its sole discretion. Carlyle Investment Management L.L.C. (“CIM” or the
“Investment Advisor”), a Delaware limited liability company, manages the Fund pursuant to the terms of the investment
advisory agreement (see Note 6, Related Party Transactions). The Investment Advisor is registered as an investment adviser
with the U.S. Securities and Exchange Commission (the “SEC”) under the Investment Advisers Act of 1940, as amended from
time to time (the “Advisers Act”). Both the General Partner and the Investment Advisor are subsidiaries of Carlyle.
13
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The interim consolidated financial statements have been prepared in accordance with accounting principles generally
accepted in the United States (“U.S. GAAP”) for interim financial information and pursuant to the requirements for reporting
on Form 10-Q and Articles 6 and 10 of Regulation S-X. The Fund is an investment company for the purposes of accounting and
financial reporting in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification
(“ASC”) Topic 946, Financial Services – Investment Companies (“ASC 946”).
The interim consolidated financial statements, including these notes, are unaudited and certain disclosures that will
accompany the annual consolidated financial statements prepared in accordance with U.S. GAAP are omitted. In the opinion of
management, all adjustments considered necessary for the fair presentation of consolidated financial statements for the interim
periods presented have been included. These adjustments are of a normal, recurring nature. This Form 10-Q should be read in
conjunction with the Fund’s Annual Report on Form 10-K. The results of operations for the periods presented are not
necessarily indicative of the operating results to be expected for the full year.
Basis of Consolidation
In accordance with ASC 946, the Fund generally does not consolidate entities unless the Fund has a controlling financial
interest in an investment company or operating company whose business consists of providing services to the Fund. The Fund
determines whether it has a controlling financial interest in an investment company or operating company at such company’s
inception or time of acquisition and continuously reconsiders this conclusion. Accordingly, the Fund consolidates in its
consolidated financial statements the accounts of certain wholly owned subsidiaries, including entities formed to hold or
aggregate investments, that meet the criteria described above. All significant intercompany balances and transactions have been
eliminated in consolidation.
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make
assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the consolidated financial statements. Management’s estimates are based on historical experiences and
other factors, including expectations of future events that management believes to be reasonable under the circumstances. It also
requires management to exercise judgment in the process of applying the Fund’s accounting policies. Actual results could differ
from these estimates and such differences could be material.
Cash and Cash Equivalents
Cash and cash equivalents consist principally of cash and/or short term investments, including overnight bank deposits,
which are readily convertible into cash and have original maturities of three months or less. The Fund is subject to credit risk
should a financial institution be unable to fulfil its obligations and if balances held at a financial institution exceed insured
limits.
Foreign Currency
The Fund’s investments may be denominated in foreign currencies and, thus, are subject to foreign currency exchange rate
fluctuations. Assets and liabilities denominated in foreign currencies are remeasured into U.S. dollars at the prevailing exchange
rate at the reporting date. Transactions denominated in foreign currencies, including purchases and sales of investments, and
income and expenses, are remeasured into U.S. dollars at the prevailing exchange rates at the respective transaction dates. The
effects of changes in foreign currency exchange rates are included in the consolidated statements of operations as part of net
change in unrealized appreciation on investments and net realized gain on investments, as applicable.
Investment Valuation
The Fund carries its investments at fair value in accordance with ASC Topic 820, Fair Value Measurement (“ASC 820”).
ASC 820 establishes a hierarchical disclosure framework which ranks the observability of market inputs used in measuring
14
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, the
characteristics specific to the investment and the state of the marketplace, including the existence and transparency of
transactions between market participants.
The Fund’s portfolio investments measured and reported at fair value are classified and disclosed based on the
observability of inputs used in the determination of fair value, as follows:
Level I — Inputs are quoted prices in active markets for identical investments as of the reporting date. The Fund does
not adjust the quoted price for such investments.
Level II — Inputs are other than quoted prices in active markets and are either directly or indirectly observable as of
the reporting date. These inputs may include quoted prices for similar investments in active markets, quoted prices for
identical or similar investments in markets that are not active, or other observable inputs.
Level III — Inputs are unobservable and significant to the overall fair value measurement. The determination of fair
value for investments classified within Level III requires significant judgment or estimation by the General Partner.
The Fund recognizes transfers between levels of the fair value hierarchy at the end of the reporting period in which the
transfer occurs.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such
cases, the classification within the hierarchy is determined based on the lowest level input that is significant to the fair value
measurement in its entirety.
In the absence of observable market prices, the Fund values its investments using valuation methodologies applied on a
consistent basis in accordance with the Fund’s valuation policies and procedures approved by the General Partner. Such
methodologies may include the market approach, which considers comparable company or transaction multiples, and the
income approach, which incorporates discounted cash flow analyses and other valuation techniques. These methods involve a
significant degree of judgment. The Fund’s valuation policies and procedures require that a sample of the Fund’s investments
be reviewed by external valuation firms monthly. The results of such reviews are communicated to the Fund’s Valuation
Committee, which includes the Fund’s Chief Executive Officer and Chief Financial Officer, as well as members of senior
management of the General Partner.
For investments in private equity funds, secondary funds and other external investment vehicles, the Fund generally
determines fair value based on its proportionate share of the most recent NAV reported by the respective underlying fund
manager, provided that such NAV is calculated in a manner consistent with ASC 820. The reported NAV is adjusted, as
necessary, for subsequent capital contributions, distributions and other known events occurring through the reporting date. To
the extent the underlying fund holds publicly traded securities, the Fund considers changes in the quoted market prices of such
securities from the date of the most recent NAV. In addition, where appropriate, the Fund may adjust the reported NAV to
reflect estimated changes in the fair value of the underlying fund’s non-public investments from the date of the most recent
NAV through the reporting date.
Investments measured using NAV as a practical expedient are not classified within the fair value hierarchy but are
disclosed separately in Note 3, Fair Value Measurements.
Income Taxes
As Carlyle Private Equity Partners Fund, L.P. is a partnership for U.S. federal and state income tax purposes, income and
losses are allocated to the individual shareholders who are responsible for reporting such and paying any taxes thereon. The
Fund anticipates filing its initial tax return in 2026. The Fund intends to operate, in part, through subsidiaries that may be
treated as corporations for U.S. and non-U.S. tax purposes. The Fund may therefore be subject to current and deferred U.S.,
state, and/or local income taxes at these subsidiaries.
The Fund accounts for income taxes using the asset and liability method, which requires the recognition of deferred tax
assets and liabilities for the expected future consequences of events that have been included in the financial statements or tax
returns. A valuation allowance is recorded on the Fund’s gross deferred tax assets when it is “more likely than not” that such
15
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
asset will not be realized. When evaluating the realizability of the Fund’s deferred tax assets, all evidence, both positive and
negative, is evaluated.
Under U.S. GAAP for income taxes, the amount of tax benefit to be recognized is the amount of benefit “more likely than
not” to be sustained upon examination. If uncertainties in tax positions exist, a liability is established. The Fund recognizes
accrued interest and penalties, if any, as a component of the provision for income taxes.
Temporary differences between the tax basis and the reported amounts of assets and liabilities within the Fund’s taxable
subsidiaries were not significant.
Calculation of Net Asset Value
The Fund calculates NAV under U.S. GAAP as of the end of each month by deducting all accrued fees, expenses and other
liabilities from the fair value of investments and other assets. Expenses directly related to the Fund or its classes are charged to
the Fund or the applicable class. Expenses directly related to the Fund and other shared expenses prorated to the Fund are
allocated to each class based on its relative net assets or other appropriate methods. Other operating expenses shared by several
funds, including other funds managed by the Investment Advisor, are prorated among those funds on the basis of relative net
assets or other appropriate methods. Net asset value per Unit for each class is calculated by dividing the net asset value for that
class by the total number of outstanding Units of that class on the reporting date.
For purposes of establishing the price at which transactions in the Fund’s Units occur, the Fund also calculates a monthly
“Transactional NAV”, which differs from the Fund’s NAV determined in accordance with U.S. GAAP, primarily due to
differences in the recognition and timing of certain fees and expenses.
Net Realized Gains or Losses and Net Change in Unrealized Gain (Loss) on Investments
Realized gains or losses on investments are recognized upon the sale, repayment, or other disposition of an investment and
are measured as the difference between the net proceeds received and the investment’s cost basis, adjusted for any previously
recognized unrealized appreciation or depreciation, with cost determined using the specific identification method.
Net change in unrealized appreciation (depreciation) on investments reflects the change in fair value of investments during
the reporting period, including the reversal of previously recorded unrealized amounts upon realization. Unrealized gains and
losses are included in the consolidated statements of operations in the period in which the change in fair value occurs.
Realized and unrealized gains and losses on derivative contracts, if any, are recognized in accordance with the Fund’s
derivative accounting policy and are presented separately in the consolidated statements of operations, as discussed below.
Derivative Instruments
CPEP enters into foreign currency forward contracts to economically hedge against foreign currency exchange rate risk on
its non-U.S. dollar denominated securities or to facilitate settlement of foreign currency denominated transactions. A foreign
currency forward contract is an agreement between two parties to buy and sell a currency at a set price with delivery and
settlement at a future date. Foreign currency forward contracts are carried at fair value and are marked-to-market at each
reporting date. Changes in fair value are recognized in net change in unrealized appreciation (depreciation) on derivative
contracts in the consolidated statements of operations.
Upon settlement or termination of a contract, realized gains or losses are recognized in net realized gain (loss) on derivative
contracts and represent the difference between the proceeds received or paid and the contract’s carrying value at the time of
settlement. Foreign currency forward contracts involve elements of market risk in excess of the amounts reflected in the
consolidated statements of assets and liabilities. The primary risk associated with these instruments is the risk of an unfavorable
change in the underlying foreign currency exchange rates.
The Fund enters into foreign currency forward contracts under ISDA master agreements with its counterparty. These
agreements provide for the netting of amounts payable and receivable with the same counterparty and permit, for foreign
currency transactions, settlement on a net basis for amounts due on the same date and in the same currency. The Fund does not
16
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
offset derivative assets and liabilities in its consolidated statements of assets and liabilities, as the conditions required for
offsetting are not met.
The Fund recognizes derivative instruments as assets or liabilities at fair value in its consolidated statements of assets and
liabilities as derivative assets at fair value and derivative liabilities at fair value, respectively.
Additional information regarding derivative instruments is included in Note 4, Derivative Instruments.
Organizational and Offering Costs
Organizational costs are expensed as incurred. Offering costs attributable to the sale of Units are capitalized as deferred
offering costs and included in other assets on the consolidated statements of assets and liabilities. Costs associated with the
offering of each of the Fund’s classes of units as described in Note 5, Net Assets, are capitalized as a deferred expense and
included as an asset on the consolidated statements of assets and liabilities. These deferred offering costs are amortized over a
twelve-month period beginning on the date incurred. Organizational and offering costs were not borne by the Fund until the
Initial Closing on October 1, 2025.
Servicing Fees
The Fund pays a servicing fee (the “Servicing Fee”) to TCG Capital Markets L.L.C. (the “Dealer Manager”) based on the
applicable annual rate of the Transactional NAV of certain Unit classes. No servicing fee is payable with respect to Class I
Units, Class A-I Units, Class E-I Units, Class C Units and Class CG Units. Additional information regarding the Servicing Fee
arrangement is included in Note 6, Related Party Transactions.
In accordance with U.S. GAAP, the Fund accrues the estimated cost of the Servicing Fee at the time Units bearing such
fees are issued and records the obligation as an offering cost.
Other Expenses
Other expenses consist primarily of fund operating costs, including administration, accounting, legal, audit, tax, servicing
and other professional fees incurred in connection with the Fund’s operations.
Segment Reporting
CPEP operates through a single reporting segment with the objective of generating investment returns by providing its
investors access to Carlyle’s platform, with an emphasis on its U.S., European, and Asian corporate buyout strategies. The chief
operating decision maker of the Fund is the Fund’s Chief Executive Officer, who primarily utilizes net increase in net assets
from operations to implement investment policy decisions, manage the portfolio and assess the performance of the Fund. As the
Fund’s operations comprise a single reporting segment, there is no difference between segment assets and total consolidated
assets as presented on the accompanying consolidated statements of assets and liabilities and the significant segment expense
are the same as those listed on the accompanying consolidated statements of operations.
17
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
3. FAIR VALUE MEASUREMENTS
The following tables summarize the valuation of the Fund’s investments, derivative assets and derivative liabilities held at
fair value by the fair value hierarchy levels as of March 31, 2026 and December 31, 2025:
 
March 31, 2026
 
Level I
Level II
Level III
NAV
Total
Assets
Cash and Cash Equivalents
Money Market Fund
$12,710
$
$
$
$12,710
Total Cash and Cash Equivalents(1)
12,710
12,710
Investments
Investments in portfolio companies
60,001
60,001
Investments in affiliated and non-
affiliated investee funds
13,575
13,575
Total Investments
60,001
13,575
73,576
Derivative Assets
493
493
Total
$12,710
$493
$60,001
$13,575
$86,779
Liabilities
Derivative Liabilities
$
$265
$
$
$265
___________________
(1)Cash held at banks of $1.5 million is carried at cost, which approximates fair value, and is therefore not included in the fair value hierarchy.
 
December 31, 2025
 
Level I
Level II
Level III
NAV
Total
Assets
Cash and Cash Equivalents
Money Market Fund
$10,833
$
$
$
$10,833
Total Cash and Cash Equivalents(1)
10,833
10,833
Investments
Investments in portfolio companies
35,962
35,962
Investments in affiliated and non-
affiliated investee funds
8,938
8,938
Total Investments
35,962
8,938
44,900
Derivative Assets
759
759
Total
$10,833
$759
$35,962
$8,938
$56,492
Liabilities
Derivative Liabilities
$
$359
$
$
$359
__________________
(1)Cash held at banks of $0.3 million is carried at cost, which approximates fair value, and is therefore not included in the fair value hierarchy.
18
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
The following tables summarize the quantitative information related to the significant unobservable inputs for Level III
instruments which are carried at fair value as of March 31, 2026 and December 31, 2025:
 
Fair Value as of
March 31, 2026
Valuation
Techniques
Significant
Unobservable
Inputs
Range
Weighted
Average
Impact to Valuation
from Increase in
Input
 
Low
High
Investments in
portfolio
companies
$60,001
Discounted Cash 
Flow
Discount Rate
8.29%
16.99%
12.14%
Lower
Terminal Growth
Rate
2.00%
11.00%
3.80%
Higher
Comparable
Multiple
EBITDA
Multiple
6.86x
20.47x
13.24x
Higher
Revenue
Multiple
4.27x
8.15x
5.13x
Higher
Total Level III
Investments
$60,001
 
Fair Value as of
December 31, 2025
Valuation
Techniques
Significant
Unobservable
Inputs
Range
Weighted
Average
Impact to Valuation
from Increase in
Input
 
Low
High
Investments in
portfolio
companies
$35,962
Discounted Cash
 Flow
Discount Rate
8.20%
16.78%
12.19%
Lower
Terminal Growth
Rate
2.00%
11.00%
4.28%
Higher
Comparable
Multiple
EBITDA
Multiple
6.31x
23.77x
14.43x
Higher
Revenue
Multiple
4.78x
8.34x
5.19x
Higher
Total Level III
Investments
$35,962
The changes in the Fund’s investments at fair value for which the Fund has used Level III inputs to determine fair value
and net change in unrealized appreciation (depreciation) included in earnings for Level III investments still held are as follows
for the three months ended March 31, 2026:
Equity Securities
Balance, beginning of period
$35,962
Purchases
21,449
Sales and proceeds from Investments
(231)
Transfers into Level III
Transfers out of Level III
Net realized gains (losses)
Net change in unrealized appreciation
2,821
Balance, end of period
$60,001
Net change in unrealized appreciation included in earnings related to investments still held
at the reporting date included in net change in unrealized appreciation on investments on
the consolidated statement of operations
$2,821
4. DERIVATIVE INSTRUMENTS
In the normal course of business, the Fund may enter into derivative contracts to achieve certain risk management
objectives. The Fund may enter into derivative instruments to hedge against foreign currency exchange rate risk on a portion or
all of its non-U.S. dollar denominated investments. These instruments primarily include foreign currency forward contracts.
The Fund utilizes forward currency contracts to economically hedge the currency exposure associated with certain foreign-
19
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
denominated investments. These derivative contracts are not designated as hedging instruments for accounting purposes. The
use of foreign currency forward contracts does not eliminate fluctuations in the price of the underlying investments recognized
by the Fund. As a result of the use of derivative contracts, the Fund is exposed to the risk that counterparties will fail to fulfill
their contractual obligations. To mitigate such counterparty risk, the Fund enters into contracts with certain major financial
institutions, all of which have investment grade ratings. Counterparty credit risk is evaluated in determining the fair value of
derivative instruments.
The tables below summarize the aggregate notional amount and fair value of the derivative instruments as of March 31,
2026 and December 31, 2025. The notional amount represents the absolute value amount of the foreign exchange contracts:
March 31, 2026
December 31, 2025
Assets
Liabilities
Assets
Liabilities
Notional
Fair Value
Notional
Fair Value
Notional
Fair Value
Notional
Fair Value
Derivative Investments
Foreign Currency Forward
Contracts (EUR)
4,548
$53
1,897
$(26)
$
5,049
$(103)
Foreign Currency Forward
Contracts (JPY)
¥1,752,396
326
¥213,605
(6)
¥1,329,690
759
¥
Foreign Currency Forward
Contracts (AUD)
A$5,527
53
A$2,647
(166)
A$
A$5,527
(216)
Foreign Currency Forward
Contracts (INR)
Rs137,430
61
Rs137,430
(67)
Rs
Rs
Foreign Currency Forward
Contracts (CAD)
C$
C$
C$
C$4,822
(40)
$493
$(265)
$759
$(359)
For the three months ended March 31, 2026, the Fund recognized $486 thousand of net realized gain and $(172) thousand
of net unrealized loss on foreign currency forward contracts. These amounts are included in net realized gain on derivative
contracts and net change in unrealized depreciation on derivative contracts, respectively, in the consolidated statements of
operations.
5. NET ASSETS
CPEP, at the direction of the General Partner, has the authority to issue an unlimited number of units of each class of units
(as defined below). CPEP offers twelve classes of units to investors, as follows:
Standard Units
Class A Units, Class S Units, Class D Units, Class I Units
Anchor Units (1)
Class A-A Units, Class A-S Units, Class A-D Units, Class A-I Units
Early Investor Units (2)
Class E-A Units, Class E-S Units, Class E-D Units, Class E-I Units
___________________
(1)Available to investors in the Initial Closing of the Fund.
(2)Available to investors in closings which occur within one year of the Initial Closing.
Additionally, Class C and Class CG Units (collectively, the “Carlyle Units”) are available for Other Carlyle Accounts (as
defined in the Partnership Agreement) that invest in the Fund as part of custom mandates and Carlyle Units are available to
Carlyle and certain of its affiliates and employees, officers and directors and other persons as determined by the General Partner
in its discretion. The Carlyle Units are not offered to other investors.
The primary differences among the classes of units relates to the Management Fee, the Servicing Fee, and upfront
subscription fees (discussed below). See Note 6, Related Party Transactions, for further detail regarding the Management Fee
and Servicing Fee by class of units.
20
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
Certain financial intermediaries may charge investors upfront selling commissions, placement fees, subscription fees, or
similar fees (“Subscription Fees”) of up to the following, as a percentage of Transactional NAV:
Subscription Fee
Classes of Units
3.00%
Class A Units, Class S Units, Class A-A Units, Class A-S Units, Class E-A Units, Class E-S Units
1.50%
Class D Units, Class A-D Units, Class E-D Units
%
Class I Units, Class A-I Units, Class E-I Units, Class C Units, Class CG Units
Units issued pursuant to the Fund’s distribution reinvestment plan are not subject to Subscription Fees. These Subscription
Fees are paid by investors outside of their investment in CPEP and are not reflected in CPEP’s NAV.
The Fund’s units are offered on a monthly basis, effective as of the first calendar day of each month. The purchase price
per unit of each class is equal to the Transactional NAV per unit for such class as of the last business day of the immediately
preceding month. Units were first issued to investors on October 1, 2025 at an initial subscription price of $25.00 per unit, and
the Transactional NAV was first determined as of October 31, 2025.
The following tables present transactions in the Units during the three months ended March 31, 2026, and the period from
Inception through March 31, 2025:
Class A-S Units
Class A-I Units
Class E-A Units
Class E-S Units
Class E-I Units
Class C Units
Units Outstanding as of December
31, 2025
29,000
868,850
11,050
809,598
95,584
Units issued
48,143
1,114,134
52,488
Non-cash redemptions (1)
(30)
Units Outstanding as of March 31,
2026
29,000
868,820
48,143
11,050
1,923,732
148,072
Class A-S Units
Class A-I Units
Class E-A Units
Class E-S Units
Class E-I Units
Class C Units
Units Outstanding as of February
11, 2025 (Inception)
Units issued
40
Non-cash redemptions
Units Outstanding as of March 31,
2025
40
___________________
(1)During the three months ended March 31, 2026, the Fund effected a non-cash redemption of Units held indirectly by the Feeder through the redemption of
Units at Transactional NAV. This redemption was undertaken to settle Servicing Fees paid by the Fund on the Feeder’s behalf. The transaction did not
involve any cash consideration and resulted in a reduction of partners’ capital in the applicable Unit Class. No redemptions were effected from third-party
investors during the period.
No Class A Units, Class S Units, Class D Units, Class I Units, Class A-A Units, Class A-D Units, Class E-D Units or Class
CG Units have been issued since Inception.
Redemption Program
At the discretion of the General Partner and in accordance with the Partnership Agreement, CPEP intends to implement a
redemption program (the “Redemption Program”), pursuant to which it expects to offer to redeem in each quarter up to 3% of
the Fund’s units outstanding (excluding the Class C Units), either by number of units or aggregate Transactional NAV. The
Redemption Program is expected to commence the quarter following the first anniversary of the Initial Closing. Class C Units
are not subject to the Redemption Program, including with respect to any redemption limits. The Fund has adopted a separate
arrangement pursuant to which Class C Units held by Carlyle or its affiliates may be redeemed on a monthly basis, generally
based on available subscription proceeds and subject to certain limitations, including where such redemptions would adversely
impact the Fund’s liquidity or where redemption requests under the Redemption Program are not fully satisfied.
21
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
Under the Redemption Program, the General Partner currently expects to redeem units quarterly using a purchase price
equal to the Transactional NAV per unit as of the date specified in the redemption offer (the “Redemption Date”). Any
redemption request for units that have not been outstanding for at least two years will be subject to an early redemption
deduction equal to 5% of the Transactional NAV of the units being redeemed, calculated as of the Redemption Date, (the
“Early Redemption Deduction”) for the benefit for CPEP and its Shareholders.
6. RELATED PARTY TRANSACTIONS
Partnership Agreement
CPEP has entered into an Amended and Restated Limited Partnership Agreement, dated October 1, 2025, with the General
Partner (the “Partnership Agreement”).
Incentive Allocation
Pursuant to the Partnership Agreement, the General Partner is entitled to receive an incentive allocation (the “Incentive
Allocation”) equal to 12.5% of the Fund’s Total Return, subject to (i) a 5% annual hurdle rate and (ii) a high water mark. The
Incentive Allocation includes a 100% catch-up provision, pursuant to which the General Partner receives 100% of returns in
excess of the hurdle until it has received 12.5% of cumulative profits for the applicable period. The Incentive Allocation is
calculated on a calendar year basis, accrued monthly and payable quarterly in arrears. The Incentive Allocation may be paid in
cash, Class C Units, and/or interests in any Lower Fund or any combination of the foregoing. The Carlyle Units are not subject
to the Incentive Allocation. For the three months ended March 31, 2026, the Fund recorded $444 thousand of Incentive
Allocation expense. As of March 31, 2026 and December 31, 2025, $444 thousand and $434 thousand, respectively, was
accrued and payable to the General Partner.
Advisory Agreement
The Fund has entered into an Investment Advisory Agreement (the “Advisory Agreement”) with the Investment Advisor,
dated October 1, 2025, pursuant to which the Investment Advisor manages the Fund and supports the Fund in managing its
investments. The Investment Advisor will not make investment decisions on behalf of CPEP and does not have the authority to
enter into contracts or commitments on behalf of CPEP.
Management Fee
In consideration for its investment management services, the Investment Advisor is entitled to receive a management fee
(the “Management Fee”) with respect to each class of units payable by CPEP, directly or indirectly through an Intermediate
Entity (including any Lower Funds), equal to, in the aggregate, 1.25% per annum of the Transactional NAV of the units
attributable to such class of units, payable monthly in arrears, before giving effect to any accruals for the Management Fee, the
Incentive Allocation, the Servicing Fee (defined below), pending unit redemptions for the month, any distributions and without
taking into account accrued and unpaid taxes (whether paid, payable accrued or otherwise) of any Intermediate Entity
(including corporations) through which CPEP indirectly invests in an Investment or taxes paid by any such Intermediate Entity
during the applicable month, as determined in the good faith judgment of the General Partner; provided, that (i) with respect to
the Anchor Units, the Management Fee shall be waived for the first twelve (12) months following the Initial Closing and shall
be equal to 0.75% of the month-end Transactional NAV attributable to the Anchor Units for twenty-four (24) months thereafter
and (ii) with respect to Early Investor Units, the Management Fee shall be equal to 0.75% per annum of the month-end
Transactional NAV attributable to the Early Investor Units for the first thirty-six (36) months following the Initial Closing.
Carlyle Units do not pay a Management Fee.
The Investment Advisor may elect to receive the Management Fee in cash, Class C Units and/or shares, units or interests of
any Lower Fund. See Note 5, Net Assets, for a definition and description of the Fund’s classes of units.
For the three months ended March 31, 2026, the Investment Advisor earned $131 thousand in Management Fees, of which
$48 thousand were waived. As of March 31, 2026 and December 31, 2025, $36 thousand and $18 thousand, respectively, in
Management Fees were payable.
22
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
Expense Support Arrangement
Pursuant to the Advisory Agreement, the Investment Advisor may advance organizational and offering expenses and
certain operating expenses on behalf of the Fund (the “Expense Support”). Organizational and offering expenses were not
allocated to the Fund until the Initial Closing on October 1, 2025.
Through and including the first twelve months following the Initial Closing, the Investment Advisor has agreed to waive a
portion of its Management Fee and/or pay, absorb or reimburse certain Fund expenses to the extent necessary so that annual
Specified Expenses do not exceed 0.60% of net assets (annualized), subject to the terms of the advisory agreement. Amounts
waived or reimbursed during this period may be subject to recoupment, provided that such recoupment would not cause
Specified Expenses to exceed the applicable limitation in the month of recoupment.
The Fund is economically responsible for advanced expenses and will reimburse the Investment Advisor in accordance
with the terms of the advisory agreement. Reimbursements may be made in cash or, at the Investment Advisor’s election, in
Class C Units, which are not subject to the volume limitations of the Fund’s redemption program. In the event of dissolution,
liquidation or termination of the advisory agreement, the Fund is obligated to reimburse any unreimbursed advances made by
the Investment Advisor.
As of March 31, 2026, the Investment Advisor had advanced approximately $6.5 million of expenses on behalf of the
Fund, of which $3.2 million is included in offering costs payable and $3.3 million is included in due to affiliates on the
accompanying consolidated statements of assets and liabilities. During the three month period ended March 31, 2026, the Fund
reimbursed the Investment Advisor $151 thousand of such advances.
Dealer Manager Agreement
On July 25, 2025, the Fund and the Feeder entered into an agreement (the “Dealer Manager Agreement”) with the Dealer
Manager, a broker-dealer registered with the SEC under the Exchange Act and a member of the Financial Industry Regulatory
Authority. Pursuant to the Dealer Manager Agreement, the Dealer Manager manages the Fund’s relationships with third-party
brokers engaged by the Dealer Manager to participate in the distribution of the Fund’s units. The Dealer Manager also
coordinates the Fund’s marketing and distribution efforts with participating brokers and their registered representatives with
respect to communications related to the terms of the Fund’s offering, its investment strategies, material aspects of its
operations, and subscription procedures.
The Dealer Manager is entitled to receive the Servicing Fee monthly in arrears at an annual rate of the Transactional NAV
of each class of Units as outlined in the following table:
Servicing Fee
(per annum)
Classes of Units (1)
0.85%
Class S Units, Class A-S Units, Class E-S Units
0.50%
Class A Units, Class A-A Units, Class E-A Units
0.25%
Class D Units, Class A-D Units, Class E-D Units
%
Class I Units, Class A-I Units, Class E-I Units, Class C Units, Class CG Units
________________
(1)See Note 5, Net Assets, for a description of the Fund’s classes of units.
The Servicing Fee is calculated based on Transactional NAV as of the end of each month before giving effect to any
accruals for the Servicing Fee, redemptions, if any, for that month and distributions payable on Units. The Servicing Fee is
payable to the Dealer Manager, but generally all or a portion of the Servicing Fee is paid to participating brokers or other
financial intermediaries.
In accordance with U.S. GAAP, the Fund accrues the cost of the Servicing Fee for the estimated life of the relevant Units
as an offering cost at the time such Units are sold. As of March 31, 2026 and December 31, 2025, the Fund has accrued $131
thousand and $74 thousand, respectively, of Servicing Fees.
23
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
Warehousing Agreement
On August 4, 2025, CPEP and the Investment Advisor, in its capacity as investment advisor of CPEP, entered into a
Warehousing Agreement with CPEP Seed Investments, L.P. (the “Warehouse Entity”), an affiliate of Carlyle. In order to
support the development of CPEP, the Warehouse Entity has, and will continue to, warehouse investments that have been
approved by the General Partner on behalf of CPEP over time as CPEP raises capital, subject in each case to the Warehouse
Entity’s approval at the time of acquisition (each, an “Approved Warehoused Investment”). The Warehouse Entity has agreed
to subsequently transfer to CPEP, and CPEP has agreed to acquire from the Warehouse Entity, such Approved Warehoused
Investments at a price as agreed to between the parties, subject to certain conditions, including that CPEP has sufficient capital
to acquire such Approved Warehoused Investments. CPEP Lux is also expected to acquire Approved Warehoused Investments
from the Warehouse Entity. The Investment Advisor will determine which and what portions of Approved Warehoused
Investments will be acquired by CPEP and CPEP Lux at each sale and transfer date.
CPEP bears its proportionate share of (a) fees, costs, and expenses, if any, incurred in developing, negotiating and
structuring any Approved Warehoused Investment that is transferred to CPEP, and (b) any broken deal expenses allocated by
Carlyle to the Warehouse Entity. The term of the Warehousing Agreement shall continue until terminated by a party upon at
least thirty calendar days’ written notice to the other parties.
During the three months ended March 31, 2026, the Fund acquired interests in 15 Approved Warehoused Investments from
the Warehouse Entity for $24.3 million. These interests were generally acquired at a price that approximated the Warehouse
Entity’s cost basis.
Feeder
The Feeder is a Delaware limited partnership formed on February 11, 2025 for the benefit of certain shareholders with
particular tax characteristics. The Feeder intends to invest all or substantially all of its investable assets in one or more entities
treated as a corporation for U.S. federal income tax purposes (a “Corporation”), which, in turn, intends to invest all or
substantially all of its investable assets in Class A-I, Class E-I and Class I Units of the Fund. The Feeder wholly owns CPEP
Blocker, L.P. (the “Blocker”), a limited partnership formed on February 21, 2025, in accordance with the laws of the Cayman
Islands, which is a Corporation for U.S. federal income tax purposes. Investors in the Feeder indirectly bear, without
duplication, their proportional share of the Fund’s expenses.
CPEP Lux
CPEP invests alongside Carlyle Private Equity Partners - EU (“CPEP Lux”), a sub-fund of Carlyle Private Markets S.A.
SICAV – UCI Part II, and a Luxembourg alternative investment fund available to individual investors primarily domiciled in
countries of the European Economic Area, the United Kingdom, Switzerland, Asia and certain other jurisdictions. While the
Fund and CPEP Lux have substantially similar investment objectives and strategies and are expected to have overlapping
investment portfolios, the Fund and CPEP Lux are operated as distinct investment structures.
Affiliates
The General Partner, Investment Advisor, Dealer Manager, Feeder, Blocker, CPEP Lux and any other vehicle sponsored,
advised and/or managed by Carlyle, are affiliates of the Fund.
7. COMMITMENTS AND CONTINGENCIES
The Fund had unfunded commitments of $6.8 million in unaffiliated investee funds and $0.1 million in affiliated investee
funds as of March 31, 2026.
The Fund has also entered into an Expense Support arrangement with the Investment Advisor, pursuant to which certain
organizational, offering and operating expenses have been advanced on behalf of the Fund and are subject to reimbursement
over time in accordance with the terms of the arrangement. See Note 6, Related Party Transactions, for additional information.
In the ordinary course of its business, CPEP may enter into contracts or agreements that contain indemnifications or
warranties. Future events could occur that lead to the enforcement of such indemnifications or warranties against the Fund.
24
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
Based on its history and experience, the General Partner believes that the likelihood of such an event is remote; however, the
maximum potential exposure is unknown.
CPEP may, from time to time, be party to various legal matters arising in the ordinary course of business, including claims
and litigation proceedings. As of March 31, 2026, CPEP was not subject to any material litigation nor was CPEP aware of any
material litigation threatened against it.
8. CONSOLIDATED FINANCIAL HIGHLIGHTS
The following financial highlights relate to investment performance and operations for each class of Unit outstanding for
the three months ended March 31, 2026.
For the three months ended March 31, 2026
Class A-S Units
Class A-I Units
Class E-S Units
Class E-I Units
Class E-A Units
Class C Units
Class Inception Date
Oct 1, 2025
Oct 1, 2025
Dec 1, 2025
Nov 3, 2025
Mar 2, 2026
Oct 1, 2025
Per Unit Data:
Net asset value per Unit,
beginning of period
$21.89
$23.84
$25.46
$27.24
$
$26.20
Proceeds from Units issued (1)
0.38
28.40
0.74
Net investment loss (2)
(0.73)
(0.78)
(0.87)
(0.92)
(0.31)
(0.67)
Net realized and unrealized
gain on investments, including
derivative contracts (2)
1.25
1.35
1.45
1.56
0.63
1.53
Servicing fees
(0.08)
(0.06)
(1.16)
Net asset value per Unit, end of
period
$22.33
$24.41
$25.98
$28.26
$27.56
$27.80
Number of Units outstanding, end
of period
29,000
868,820
11,050
1,923,732
48,143
148,072
Total return based on net asset
value (3)
2.01%
2.39%
2.04%
3.74%
(2.96)%
6.11%
Ratio to Weighted-Average Net
Assets(4):
Incentive Allocation
(0.85)%
(0.78)%
(0.70)%
(0.65)%
(0.25)%
%
Total Expenses before waived
expenses
(3.82)%
(3.73)%
(3.64)%
(3.57)%
(1.19)%
(2.72)%
Total waived expenses
0.24%
0.22%
%
%
%
%
Total Expenses after waived
expenses
(3.57)%
(3.50)%
(3.64)%
(3.57)%
(1.19)%
(2.72)%
Net investment loss
(3.31)%
(3.24)%
(3.37)%
(3.31)%
(1.11)%
(2.46)%
________________
(1)Represents the per Unit impact of subscriptions during the period. The difference between issuance price (Transactional NAV) and U.S. GAAP net asset
value throughout the period, as well as the timing of Unit issuances, may result in subscriptions may be accretive (or dilutive) to net asset value per Unit. 
(2)Net investment loss per Unit was calculated as net investment loss for the period divided by the weighted average number of Units outstanding for the
period.
(3)Total return based on net asset value (not annualized) is calculated as the change in net asset value per Unit during the period divided by the net asset
value per Unit at the beginning of the period. For unit classes with an inception date during the period, total return is calculated as the change in net asset
value per Unit from the Class inception date through March 31, 2026 divided by the net asset value per Unit at the Class inception date. Total return does
not include upfront transaction fees, if any.as of the beginning of the period. For unit classes with an inception date during the period, total return is
calculated from the class inception date.
(4)These ratios to average net assets have not been annualized.
25
Table of Contents
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS, CONTINUED
(All Dollars are in Thousands, Except Unit and Per Unit Data, except as noted) (unaudited)
9. SUBSEQUENT EVENTS
Subsequent to March 31, 2026, CPEP accepted subscriptions for an additional $22.5 million in connection with its April
and May closings bringing inception to date subscriptions in its continuous private offering to $103.7 million.
Subsequent to March 31, 2026, CPEP acquired interests in Approved Warehouse Investments from the Warehouse Entity,
an affiliate of Carlyle, for a total purchase price of $8.1 million.
There have been no events since March 31, 2026, other than those already disclosed, that require recognition or disclosure
in the consolidated financial statements.
26
Table of Contents
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Unless context suggests otherwise, references in this report to “CPEP,” the “Fund,” “we,” “us,” and “our” refer to
Carlyle Private Equity Partners Fund, L.P. and references in this report to “Carlyle” refer collectively to The Carlyle Group
Inc. and its subsidiaries and affiliated entities. The following discussion and analysis should be read in conjunction with the
consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q.
Overview
CPEP is a Delaware limited partnership formed on February 11, 2025 as a private fund exempt from registration pursuant
to Section 3(c)(7) of the Investment Company Act of 1940, as amended (the “1940 Act”). Our general partner, CPEP GP, LLC
(the “General Partner”), and our investment advisor, Carlyle Investment Management L.L.C. (the “Investment Advisor”), are 
affiliates of Carlyle.
Our investment objective is to generate attractive risk-adjusted returns and achieve medium-to-long-term capital
appreciation through a well-diversified portfolio of private equity investments. We seek to achieve our investment objective by
providing access to Carlyle’s Global Private Equity (“GPE”) platform, with an emphasis on its U.S., European, and Asian
corporate buyout strategies. We also provide investors access to Secondary Investments through Carlyle AlpInvest, as well as
certain other investment strategies, such as growth, infrastructure and, in certain instances, Global Credit. We expect to access
these private equity investments in a variety of ways, including through:
Direct Investments: Investments in companies and other private assets which may include, without limitation, private
and public investments in equity instruments, preferred equity instruments, convertible debt or equity derivative
instruments, warrants, options, “PIK” (paid-in-kind) notes, mezzanine debt, hybrid capital (including, but not limited
to, structured equity, distressed credit and opportunities arising due to market dislocation), collateralized loan
obligation equity, other debt investments and “PIPE” (private investments in public equity) transactions;
Secondary Investments: Certain secondary investments of Carlyle AlpInvest which target investments in private equity
assets and private equity funds managed by third-party managers and portfolios of direct private equity investments
through privately negotiated transactions (typically structured through new investment vehicles) in the secondaries
market and from time to time may include secondary market purchases of existing investments in Other Carlyle
Accounts; and
Primary Commitments: Capital commitments to investment funds managed by Carlyle or third-party managers.
CPEP may also invest in continuation vehicles sponsored by Carlyle or third-party managers and may invest alongside
other third-party managers in investments acquired from Other Carlyle Accounts. Further, CPEP may create, invest or co-invest
with Other Carlyle Accounts or third parties in platform arrangements, including existing companies or newly-formed
investment vehicles, to pursue investment opportunities that may lead to the creation or expansion of Portfolio Companies.
While we frequently expect to invest in or alongside Other Carlyle Accounts, we may be the sole Carlyle-sponsored vehicle
participating in an investment.
Additionally, CPEP may invest in debt and other types of liquid securities, including but not limited to loans, debt
securities, public equities, shares and/or units of exchange traded funds, collateralized debt obligations, collateralized loan
obligations, asset-backed securities, mortgage-backed securities and other securitized products, derivatives, total return swaps,
money market instruments, investment companies and cash and cash equivalents (each such transaction or series of transactions
in single or multiple assets, a “Liquid Investment” and together with Direct Investments, Secondary Investments and Primary
Commitments, “Investments”), in each case in order to provide us with income, manage overall portfolio risk and to provide a
potential source of liquidity for the Redemption Program.
We generally seek to invest 80-90% of our NAV in a global portfolio of private equity investments consisting of Direct
Investments, Secondary Investments and Primary Commitments and up to 10-20% of our NAV in Liquid Investments. Our
Investments may vary materially from these indicative allocation ranges, including due to factors such as a large inflow of
capital over a short period of time, the General Partner’s assessment of the relative attractiveness of opportunities, or an
increase in anticipated cash requirements or redemption requests and subject to any limitations or requirements relating to
applicable law. Certain Investments could be characterized by the General Partner, in its discretion, as either Direct Investments
or Liquid Investments depending on the terms and characteristics of such Investments. For the avoidance of doubt, in the event
that our Investments vary from the ranges indicated above for any reason, the General Partner shall have no obligation to sell
any Investments or take any other action to remedy such variances and may determine to maintain a different target ratio in the
future.
27
Table of Contents
We may use financial leverage for any purpose, including to provide additional funds to support our investment activities,
and leverage may be used more heavily in certain investment strategies, particularly during the initial ramp-up period. We do
not intend to incur cash borrowings to finance the acquisition of an Investment if such borrowings would cause the aggregate
amount of recourse indebtedness for borrowed money incurred by us for purposes of acquiring Investments to exceed 30% of
our total assets, measured at the time we make such borrowings, except that such limit will not apply to the extent we incur
borrowings to provide interim financing prior to the receipt of capital. In addition, there is, however, no limit on the amount we
may borrow with respect to our Portfolio Companies or joint ventures that is not recourse to the Fund. During the initial ramp-
up period, our leverage may exceed such target. We may also exceed a leverage ratio of 30% at other times, particularly during
a market downturn or in connection with a large acquisition.
At the discretion of the General Partner and in accordance with our Amended and Restated Limited Partnership Agreement
(as amended, restated or supplemented from time to time, the “Partnership Agreement”), we expect to implement a redemption
program pursuant to which we expect to redeem in each quarter up to 3% of Investor Units and Class CG Units outstanding
(either by number of Units or aggregate NAV) (the “Redemption Program”). The Redemption Program is expected to
commence the quarter following the first anniversary of the Initial Closing, although the General Partner retains discretion to
commence the Redemption Program prior to such date. The General Partner may amend or suspend the Redemption Program if
in its reasonable judgment it deems such action to be in the Fund’s best interest, including, but not limited to, for tax, regulatory
or other structuring reasons. As a result, the Redemption Program may not be available each quarter, such as when the
Redemption Program would place an undue burden on our liquidity, adversely affect our operations or risk having an adverse
impact on the Fund that would outweigh the benefit of the Redemption Program, in each case as determined by the General
Partner in its sole discretion and in accordance with the Partnership Agreement.
Recent Developments
Business Environment and Outlook
The commencement of hostilities in the Middle East and the closure of the Strait of Hormuz have not yet manifested as
visible economic damage. However, risks to the global economy remain elevated as the conflict in the Middle East persists, and
those risks will continue to rise for as long as the Strait remains effectively shut. In the U.S., which is less reliant on imports
that traverse the Strait, economic activity remained relatively resilient, supported by continued business investment, including
AI-related spending. However, increases in energy prices and the potential impacts of prolonged disruptions to supply chains
introduce risks to overall growth and consumer demand. Macroeconomic conditions varied across regions elsewhere. China,
which was able to import oil from Iran in March, and Taiwan and South Korea, which continued to benefit from the AI
buildout, were particularly resilient. Those more exposed to energy imports, including Europe and India, faced increased risks
related to potential supply disruptions.
Public equity markets experienced volatility during the quarter, including sector rotations associated with changing
expectations for AI-related investment and the impact of geopolitical developments. However, after ending the quarter down
4.6%, the S&P 500 rallied to new all-time highs in May on optimism for an end to the conflict coupled with upgrades to
“consensus” earnings estimates. This recent rally is a symptom of the difficulty investors face in hedging and quantifying
geopolitical risk. In contrast to other discrete shocks, such as the failure of SVB in 2023, markets face less clarity in mapping
out the trajectory of evolving geopolitical developments and so tend to “look through” them. The shock also reaffirmed the
notion that bonds no longer hedge equity market risk. Bonds have now sold off with stocks during each major shock of the last
12 months, and the correlation between the monthly returns of stocks and bonds has moved from -25% to +50% since 2022. As
the “natural” hedge of the traditional 60/40 portfolio continues to dissolve, investors may choose to rotate towards private
markets to achieve greater diversification.
Private equity activity reflected mixed conditions. While overall M&A volumes increased, driven by larger transactions,
leveraged buyout activity and exit volumes declined compared to prior periods. Initial public offering activity remained
subdued, and broader market volatility and liquidity conditions may affect exit timing across the industry.
Given CPEP’s diversified exposure across sectors and geographies, these conditions may affect investment deployment,
valuation levels, and portfolio performance.
28
Table of Contents
Subsequent Notable Transactions
Subsequent to March 31, 2026, CPEP accepted subscriptions for an additional $22.5 million in connection with its April
and May closings bringing inception to date subscriptions in its continuous private offering to $103.7 million.
Subsequent to March 31, 2026, CPEP acquired interests in Approved Warehouse Investments from the Warehouse Entity,
an affiliate of Carlyle, for a total purchase price of $8.1 million.
For additional information, see Note 6, Related Party Transactions, to the consolidated financial statements included in
Part I, Item 1. Financial Statements.”
Portfolio and Investment Activity
During the period, the Fund completed 16 investment transactions, consisting of 5 new investments and 11 follow-on
investments in existing portfolio investments, for an aggregate purchase price of $25.7 million. These acquisitions were sourced
through a combination of investments acquired from the Warehouse Entity and investments sourced directly from general
partners. These investments consist primarily of global buyout and secondary investments diversified across aerospace and
defense, technology, financial services, industrial, consumer and healthcare sectors and across North America, Europe and
Asia-Pacific.
The charts below present the diversification of CPEP’s portfolio companies by strategy, sector and geography based on the
fair value of our investments as of March 31, 2026.
Pie Charts - MDA - same as factsheet.jpg
___________   
Totals may not foot due to rounding.
Current portfolio composition is not necessarily indicative of the future composition of the portfolio of CPEP.
Industry and geography classifications are presented on a look-through basis to the underlying portfolio companies held directly or indirectly through
investee funds. Geography is generally based on the region where each underlying portfolio company is headquartered. “Other Asia” currently includes
India; the composition of this category may change over time and may include other countries in the future.
Strategy and industry are based solely on Carlyle’s analysis and reflect solely Carlyle’s opinion.
The portfolio composition presented in the charts above differs from the presentation in the accompanying condensed consolidated schedules of
investments included in Part I, Item 1 of this Quarterly Report on Form 10-Q. The condensed consolidated schedules of investments presents investments
at the investee fund level and is not presented on a full look-through basis to the underlying portfolio companies.
29
Table of Contents
As of March 31, 2026, CPEP’s ten largest investments, based on fair value, were:
Company
Strategy
Geography
Sector
Knack RCM
International Exposure
Other Asia
Healthcare
Kyoden Co., Ltd.
International Exposure
Japan
Technology
Mantech (1)
Scale
North America
Aerospace & Defense
Sedgwick Inc.
Scale
North America
Financial Services
Tarrytown Expocare Pharmacy
Scale
North America
Healthcare
Trucordia
Opportunistic
North America
Financial Services
TRYT Inc.
International Exposure
Japan
Industrials
Vantive
Scale
North America
Healthcare
Waste Services Group Pty Ltd
International Exposure
Australia
Industrials
Worldpac
Scale
North America
Industrials
___________   
Investments listed in alphabetical order.
(1)Represents an investment in an affiliated investee fund which has been presented on a look-through basis.
Performance Summary
The chart below shows the inception to date total return for each class of Units outstanding as of March 31, 2026:
Unit Class
Class Inception Date
Year To Date Total
Return (2)
Inception To Date
Total Return (1)
Class A-I
Oct 1, 2025
4.74%
15.93%
Class E-I
Nov 3, 2025
4.56%
11.19%
Class A-S
Oct 1, 2025
4.53%
15.61%
Class E-S
Dec 1, 2025
4.42%
6.38%
Class E-A
Mar 2, 2026
1.76%
1.76%
Class C (3)
Oct 1, 2025
5.41%
18.36%
___________   
(1)Inception to date returns shown reflect the percentage change in Transactional NAV per Unit from the Class inception date through March 31, 2026.
Returns shown are reflective of each unit class and not of an individual investor. The Fund believes total return is a useful measure of overall investment
performance of our Units.
(2)Year to date returns reflect the percentage change in Transactional NAV per Unit from December 31, 2025 through March 31, 2026. For unit classes with
an inception date during the period, year to date return is calculated from the class inception date through March 31, 2026. Accordingly, for such classes,
the year to date return is equal to the inception to date return.
(3)The initial 40 Class C Units were purchased by the General Partner prior to the Fund’s commencement of operations. Performance for Class C Units is
calculated beginning October 1, 2025, the date the Fund commenced operations.
Key Components of Our Consolidated Results of Operations
Investment Income
CPEP generates investment income primarily from its investments, including dividends and distributions on its Direct
Investments, Secondary Investments and Primary Commitments. To a lesser extent, we also generate investment income in the
form of interest and dividend income from our investments in Liquid Investments, which may be used to generate income,
manage overall portfolio risk and provide a potential source of liquidity.
Dividend Income. Dividend income for the period consisted solely of income earned on investments in money market
funds. The Fund did not receive any dividend income from portfolio companies since its inception.
Interest Income. Interest income consists of interest earned on cash balances held in interest-bearing bank accounts.
Expenses
Organizational and Offering Expenses. Organizational and offering costs are costs incurred in connection with the Fund’s
organization and the offering of its Units to investors. Organizational and offering costs were only borne by CPEP once it first
30
Table of Contents
accepted third-party investors and began investment operations and activities (the “Initial Closing,” which occurred on October
1, 2025, as discussed above). Following the Initial Closing, costs associated with the organization of the Fund were expensed as
incurred.
The Investment Advisor advanced organizational and offering costs on the Fund’s behalf through the Initial Closing and
may, in its sole discretion, advance all or a portion of our organizational and offering costs and/or other costs and expenses of
our operations (the “Expense Support”) through such date as determined by the Investment Advisor. The Investment Advisor
determines the allocation of such Expense Support among the Fund and related entities. The Fund remains economically
responsible for such advanced expenses following the Initial Closing, subject to a specified expense cap and reimbursement
limitations described below. The Investment Advisor, in its sole discretion, may waive its right to reimbursement for any such
advanced expenses.
Through and including the first twelve months following the Initial Closing, the Investment Advisor has agreed to forgo an
amount of its monthly Management Fee and/or pay, absorb or reimburse certain of our expenses, to the extent necessary so that,
for any fiscal year, our annual Specified Expenses (as defined below) do not exceed 0.60% of our net assets (annualized) as of
the end of each calendar month. During the period, the Fund limited payments to the Investment Advisor in order to reflect the
application of this expense cap in the calculation of the Transactional NAV. The Fund may be required to repay the amount of
any foregone Management Fee and expenses paid, absorbed or reimbursed by the Investment Advisor during such twelve-
month period, when and if requested by the Investment Advisor, but only if and to the extent that such Specified Expenses plus
any recoupment do not exceed 0.60% of our net assets (annualized) during the applicable month. The Investment Advisor may
recapture a Specified Expense at any time, including in the same year it is incurred. This arrangement cannot be terminated
prior to the first anniversary of the Initial Closing without the consent of our board of directors. Unless this arrangement is
extended, after the first anniversary of the Initial Closing, we will reimburse the Investment Advisor for any Expense Support
that it has incurred on our behalf as and when incurred, regardless of when such Expense Support was incurred and without
regard to the 0.60% cap described above. “Specified Expenses” is defined to include all expenses incurred in the business of the
Fund, including Organizational and Offering Expenses and Fund Expenses (as defined in the Partnership Agreement), with the
exception of (i) the Management Fee, (ii) the Incentive Allocation, (iii) the Servicing Fee, (iv) Portfolio Company or joint
venture level expenses, (v) brokerage costs or other investment-related out-of-pocket expenses, including with respect to
unconsummated transactions, (vi) dividend/interest payments (including any dividend payments, interest expenses, commitment
fees, or other expenses related to any leverage incurred by the Fund), (vii) taxes, (viii) ordinary corporate operating expenses,
(ix) certain insurance costs and (x) extraordinary expenses (as determined in the sole discretion of the Investment Advisor).
Incentive Allocation. Incentive Allocation represents performance-based compensation payable to the General Partner
based on the Fund’s results relative to the applicable performance thresholds, as defined in the Partnership Agreement. During
the period, the Fund recognized Incentive Allocation expense reflecting the Fund’s performance for the period.
Management Fee. Management fees represent fees payable to the Investment Advisor for investment management and
operational services provided to the Fund. Following the Initial Closing, management fees were accrued in accordance with the
terms of the Advisory Agreement, taking into account applicable fee structures by unit class.
See Note 6, Related Party Transactions, to the consolidated financial statements included in Part I, Item 1. Financial
Statements” of this report for more information regarding the Incentive Allocation and Management Fee.
Other Expenses. Other expenses consist primarily of fund operating costs, including administration, accounting, legal,
audit, tax, servicing and other professional fees incurred in connection with the Fund’s operations.
Realized Gain (Loss) and Net Change in Unrealized Gain (Loss) on Investments and Derivative Contracts
Realized gains or losses are measured as the difference between the net proceeds from the sale, repayment, or disposal of
an asset and the adjusted cost basis of the asset, without regard to unrealized gains or losses previously recognized. Net change
in unrealized gains or losses reflects the change in investment values during the reporting period, including any reversal of
previously recorded unrealized gains or losses, when gains or losses are realized.
Consolidated Results of Operations
From inception through September 30, 2025, CPEP had not commenced principal operations. The Fund completed its
Initial Closing and commenced investment operations on October 1, 2025. The results of operations for the three months ended
March 31, 2026 reflect the Fund’s ongoing investment activities and are discussed below.
31
Table of Contents
Net Investment Income (Loss)
For the three months ended March 31, 2026, CPEP’s net investment loss was $2.2 million, attributable to $2.4 million of
total expenses, partially offset by $0.2 million of interest income and dividend income from money market funds. Total
expenses for the three months ended March 31, 2026 consisted primarily of offering expenses and professional fees of $0.8
million and $0.7 million, respectively, incentive allocation of $0.4 million and administration fees of $0.2 million.
Net Realized Gain (Loss) on Investments and Derivative Contracts
For the three months ended March 31, 2026, the Fund recognized net realized gains on investments and derivative
contracts of $54 thousand and $0.5 million, respectively. Net realized gains on investments were primarily attributable to
realization of investments through distributions received from underlying funds, while net realized gains on derivative contracts
related to the settlement of derivative contracts during the period.
Unrealized Gain (Loss) on Investments and Derivative Contracts
For the three months ended March 31, 2026, CPEP recognized $3.3 million of net unrealized gain on investments and
derivative contracts. A portion of the net change in unrealized appreciation on investments is attributable to investments
acquired throughout the three months ended March 31, 2026 from the Warehouse Entity and subsequently marked to estimated
fair value as of year end. These interests were generally acquired at a price that approximated the Warehouse Entity's cost basis.
As this included acquired assets that had appreciated above their original cost basis, the Fund recognized unrealized gains from
the mark to the estimated fair value. See Note 6, Related Party Transactions, to the consolidated financial statements included in
Part I, Item 1. Financial Statements” of this report for additional information regarding the Warehousing Agreement.
Excluding these transactions, the net change in unrealized appreciation on investments would be lower and may not be
indicative of future performance.
Financial Condition, Liquidity, and Capital Resources
The Fund generates cash primarily from the net proceeds of its continuous private offering of Units, cash flows from
operations and any financing arrangements the Fund may enter into in the future. The Fund believes that cash provided by such
means will be sufficient to satisfy its anticipated cash requirements for the next twelve months and the foreseeable future. The
primary use of the Fund’s cash and cash equivalents are for acquiring Investments, funding the cost of its operations, including
the Management Fee and Incentive Allocation, to the extent paid in cash, debt service of any borrowings, periodic redemptions
under the Redemption Program and cash distributions, if any, to Shareholders, to the extent declared by the General Partner.
As of March 31, 2026, CPEP had $14.2 million in cash and cash equivalents.
Contractual Obligations and Commitments
For contractual obligations and commitments extending beyond March 31, 2026, see Note 7, Commitments and
Contingencies, to the consolidated financial statements included in Part I, Item 1. Financial Statements” of this report.
TRANSACTIONAL NAV
The Fund calculates the Transactional NAV for purposes of establishing the price at which transactions in the respective
Units are made. For a description of the Fund’s valuation process, see “Part II, Item 5. Market for Registrant’s Common Equity,
Related Stockholder Matters and Issuer Purchases of Equity Securities—Calculation of Transactional NAV” in our Annual
Report on Form 10-K for the period ended December 31, 2025. Transactional NAV is based on the month-end values of the
Fund’s investments and other assets (including cash and cash equivalents) and the deduction of any respective liabilities,
including certain fees and expenses (such as the Incentive Allocation and Management Fee, as applicable to the respective
class), in all cases as determined in accordance with the Valuation Policy. Transactional NAV differs from the Fund’s net asset
value as determined in accordance with U.S. GAAP. A reconciliation of Transactional NAV to the Fund’s net asset value under
U.S. GAAP is included below.
The following table provides a breakdown of the major components of the Fund’s Transactional NAV as of March 31,
2026 (dollars in thousands):
32
Table of Contents
Components of CPEP’s Transactional NAV
Consolidated NAV
Investments, at fair value
$73,576
Derivative assets, at fair value
493
Cash and cash equivalents
14,219
Other assets
285
Derivative liabilities, at fair value
(265)
Accrued incentive allocation
(444)
Other liabilities
(103)
Management fee payable
(36)
Transactional NAV
$87,725
The following table provides a breakdown of the Fund’s Transactional NAV by class as of March 31, 2026:
As of March 31, 2026
Class
Number of Units
Transactional NAV
per Unit(1)
Transactional NAV
($ in thousands)
Class A-I
868,820
$28.98
$25,180
Class A-S
29,000
28.90
838
Class E-I
1,923,732
28.91
55,615
Class E-S
11,050
28.88
319
Class E-A
48,143
28.90
1,391
Class C
148,072
29.59
4,382
3,028,817
$87,725
___________   
(1)Transactional NAV does not take into consideration any class-specific fees, expenses and other net assets and liabilities attributable to the classes at the
Feeder.
The following table reconciles the Fund’s U.S. GAAP NAV to Transactional NAV (dollars in thousands):
March 31, 2026
U.S. GAAP Net Asset Value
$81,952
Adjustments
Organizational, offering, and other Fund expenses (1)
5,642
Servicing Fees (2)
131
Transactional NAV
$87,725
___________   
(1)Represents an adjustment reflecting the difference between Fund, organizational and offering expenses recognized under U.S. GAAP, which include all
expenses incurred during the period, and the amount paid to the Investment Advisor for purposes of calculating Transactional NAV, which is limited in
accordance with the Expense Support arrangement.
(2)Servicing Fees apply to certain Unit classes. As of March 31, 2026, although Units were outstanding in multiple classes, only Class A-S, Class E-A and
Class E-S Units were subject to Servicing Fees. For purposes of CPEP’s Transactional NAV, Servicing Fees are recognized as a reduction of CPEP’s
Transactional NAV on a monthly basis as they are paid. For purposes of calculating net asset value in accordance with U.S. GAAP, the Fund accrues the
cost of the Servicing Fees, as applicable, for the estimated life of the units as an offering cost at the time the Fund sells the applicable Units.
Critical Accounting Estimates
The preparation of our consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. These estimates and judgments are
based on historical information, information currently available to us and on various other assumptions management believes to
be reasonable under the circumstances. Actual results could vary from those estimates and we may change our estimates and
assumptions in future evaluations. Changes in these estimates and assumptions may have a material effect on our results of
operations and financial condition. There have been no material changes in the critical accounting estimates since those
discussed in our Annual Report on Form 10-K for the period ended December 31, 2025.
33
Table of Contents
Recent Accounting Developments
There were no accounting pronouncements issued during the three months ended March 31, 2026 that are expected to have
a material impact on our consolidated financial statements included in this Quarterly Report on Form 10-Q.
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
Uncertainty with respect to economic conditions introduces significant volatility in the financial markets, and the effect of
that volatility could materially impact our market risks. We are subject to financial market risks, including fair value risk,
foreign exchange risk and interest rate risk.
Fair Value Risk
CPEP makes Investments which are reported at fair value as determined in accordance with our Valuation Policy. There is
no single standard for determining fair value. As a result, determining fair value requires that judgment be applied to the
specific facts and circumstances of each Investment while employing a consistently applied valuation process for the types of
Investments we make. Based on the fair value of the Fund’s Investments as of March 31, 2026, management estimates that an
immediate, hypothetical 10% decline in the fair value of such Investments would result in a decline in the net change in
unrealized appreciation on Investments of $7.4 million.
Interest Rate Risk
Changes in credit markets and in particular, interest rates, can impact investment valuations and may have offsetting results
depending on the valuation methodology used. Additionally, low interest rates related to monetary stimulus and economic
stagnation may also negatively impact expected returns on all investments, as the demand for relatively higher return assets
increases and supply decreases. As of March 31, 2026, the Fund had no indebtedness.
Exchange Rate Risk
The Fund holds investments that are denominated in foreign currencies. The Fund’s primary exposure to exchange rate risk
relates to movements in the value of exchange rates between the U.S. dollar and other currencies in which the Investments are
denominated, net of the impact of foreign exchange hedging strategies, if any. As of March 31, 2026, CPEP held foreign
currency contracts through a consolidated subsidiary to hedge a change in exchange rates against the U.S. dollar.
Management estimates that an immediate, hypothetical 10% decline in the exchange rates between the U.S. dollar and
other currencies in which the Fund’s Investments were denominated as of March 31, 2026 (i.e., an increase in the value of the
U.S. dollar against these foreign currencies) would result in a decline in the net change in unrealized appreciation on
investments of $302 thousand.
ITEM 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a‐15(e) and 15d‐15(e) under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are designed to ensure that information required to be
disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported
within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to
our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal
Financial Officer), as appropriate, to allow timely decisions regarding required disclosure. In designing disclosure controls and
procedures, our management necessarily was required to apply its judgment in evaluating the cost‐benefit relationship of
possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon
certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in
achieving its stated goals under all potential future conditions. Any controls and procedures, no matter how well designed and
operated, can provide only reasonable assurance of achieving the desired objectives.
34
Table of Contents
As of the end of the period covered by this report, our management, including our Chief Executive Officer and Chief
Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the
Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the
end of the period covered by this report, our disclosure controls and procedures are effective at the reasonable assurance level to
accomplish their objectives of ensuring that information we are required to disclose in reports that we file or submit under the
Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms,
and that such information is accumulated and communicated to our management, including our Chief Executive Officer and
Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Controls over Financial Reporting
There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a‐15(f) and
15d‐15(f) under the Exchange Act) during the most recent fiscal quarter ended March 31, 2026 that have materially affected, or
are reasonably likely to materially affect, our internal control over financial reporting.
35
Table of Contents
PART II – OTHER INFORMATION
ITEM 1. Legal Proceedings
The Fund is not currently subject to any material legal proceedings, nor, to our knowledge, are any material legal
proceedings threatened against us. From time to time, the Fund may be a party to certain legal proceedings in the ordinary
course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio
companies. The Fund may also be subject to regulatory proceedings.
ITEM 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in “Part
I., Item 1A. Risk Factors” in our Annual Report on Form 10-K for the period ended December 31, 2025, which could materially
affect our business, financial condition, and/or operating results. The risks described in our Annual Report on Form 10-K are
not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be
immaterial also may materially adversely affect our business, financial condition, and/or operating results.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
All sales of unregistered securities during the three months ended March 31, 2026 were previously disclosed.
ITEM 3. Defaults Upon Senior Securities
Not applicable.
ITEM 4. Mine Safety Disclosures
Not applicable.
ITEM 5. Other Information
None.
36
Table of Contents
ITEM 6. Exhibits
A list of exhibits required to be filed or furnished as part of this report is set forth in the Exhibit Index below.
Exhibit Index
Exhibit No.
Description
3.1
3.2
31.1
 
 
31.2
 
 
32.1
 
 
32.2
 
 
101.INS
Inline XBRL Instance Document - the Instance Document does not appear in the Interactive Data File
because its XBRL tags are embedded within the Inline XBRL document.
101.SCH
Inline XBRL Taxonomy Extension Schema Document.
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB
Inline XBRL Taxonomy Extension Labels Linkbase Document.
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104
Cover Page Interactive Data (included within the Exhibit 101 attachments).
___________________
* Filed herewith
** Furnished herewith
37
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized.
 
CARLYLE PRIVATE EQUITY PARTNERS FUND, L.P.
Dated: May 14, 2026
By:
 
 
/s/ Charles E. Andrews, Jr.
 
 
Charles E. Andrews, Jr.
Chief Financial Officer
(Principal Financial Officer and Principal Accounting
Officer)

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-31.1

EX-31.2

EX-32.1

EX-32.2

XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: cpep-20260331_htm.xml